hg_184047.1

Basic information about the TSS

---

TSS ID: hg_184047.1 Species: human Chr: chr20		Start: 32359349 End: 32359359 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000643168.1 Distance: -113 GeneID: 171023 HGNC/MGI_ID: HGNC:18318 UniProt_ID: A0A2R8Y627

Gene_name: ASXL transcriptional regulator 1 Gene_symbol: ASXL1 Gene_synonyms: KIAA0978 Gene_source: HGNC:18318

TATA-Box annotation

---

Distance to TSS:	289
Nearest PromoterID:	NM_001363734
Entrez ID:	171023
Nearest Unigene:	Hs.374043
Nearest Refseq:	NM_015338
Nearest Ensembl:	ENSG00000171456
Gene Name:	ASXL transcriptional regulator 1
Gene Alias:	BOPS|MDS
Gene Description:	ASXL transcriptional regulator 1
Gene Type:	protein-coding
CpG%:	0.04
GC%:	0.562189
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ASXL1 p2@ASXL1 p3@ASXL1 p4@ASXL1 p5@ASXL1 p6@ASXL1 p7@ASXL1 p9@ASXL1
Sample		p1@ASXL1	p2@ASXL1	p3@ASXL1	p4@ASXL1	p5@ASXL1	p6@ASXL1	p7@ASXL1	p9@ASXL1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	96.82	18.90	2.53	2.34	0.78	0.00	0.19	5.84
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	93.88	19.62	2.43	1.21	0.20	0.00	0.40	4.65
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	100.12	16.40	2.70	2.12	0.39	0.00	0.39	4.24
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	84.20	17.67	2.70	1.66	0.42	0.00	0.00	6.86
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	96.29	20.70	4.05	2.47	0.00	0.00	0.67	4.72
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	106.40	12.60	1.74	2.71	1.16	0.00	0.19	3.10
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	119.62	23.53	4.79	2.61	0.44	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	107.30	17.92	2.42	1.94	0.48	0.00	0.48	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	101.09	26.93	2.99	2.78	0.43	0.00	0.00	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	199.39	23.76	2.32	5.22	0.00	0.58	0.00	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	162.91	29.51	1.21	2.83	0.81	0.00	0.40	4.45
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	180.92	32.93	1.63	4.07	0.41	0.00	1.22	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	59.16	6.77	0.64	1.13	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.41	6.62	1.05	0.75	0.30	0.00	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	44.79	10.32	1.10	1.10	0.66	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	50.80	6.29	1.51	0.25	0.25	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	47.83	5.90	1.09	1.31	0.22	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	69.60	5.91	0.84	0.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	58.65	4.80	1.60	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	50.55	3.76	0.60	1.05	0.90	0.00	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.91	6.42	0.67	0.67	0.13	0.13	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	45.92	4.66	0.86	0.17	0.35	0.00	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.69	4.39	0.90	0.39	0.39	0.13	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	42.71	5.58	1.46	0.97	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.15	7.74	1.03	1.29	0.26	0.26	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	57.61	7.28	1.90	0.95	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	76.37	5.49	0.55	1.65	1.10	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	58.70	5.19	1.89	3.06	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.87	4.36	1.29	0.48	0.65	0.00	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.36	3.80	1.63	1.45	1.09	0.00	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	36.43	1.88	0.21	1.67	0.63	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.12	3.13	1.17	1.95	0.39	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	49.59	3.80	0.63	1.27	0.21	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.05	4.62	0.49	1.32	0.49	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.04	4.67	1.50	1.68	0.00	0.00	0.00	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	35.64	5.75	0.77	1.34	0.00	0.00	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	27.80	3.47	1.02	1.23	0.82	0.20	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.98	2.01	0.60	1.61	0.40	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.17	5.13	0.81	1.35	0.27	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.81	4.80	1.44	0.96	0.48	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	25.17	3.29	1.18	0.94	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	29.86	4.10	1.17	1.17	0.44	0.15	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	33.53	4.01	0.84	1.48	0.00	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	35.14	5.24	1.05	1.22	0.17	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.31	7.03	1.61	0.80	0.60	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.85	6.51	0.93	1.16	0.23	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	39.34	7.20	2.64	0.96	0.00	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	39.34	5.07	0.60	1.19	0.30	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	48.11	7.18	0.72	0.96	0.24	0.48	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	43.47	4.85	1.01	1.01	0.40	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	44.68	8.40	1.23	1.43	0.00	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	42.25	6.45	1.78	0.67	0.67	0.67	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	13.99	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.84	4.26	1.42	1.06	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	27.17	2.32	0.99	1.66	0.33	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	91.44	14.26	0.00	3.36	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.95	8.73	0.92	1.84	0.00	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.72	3.89	0.32	0.65	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.55	5.14	1.28	0.96	0.64	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	33.00	5.97	1.26	0.31	0.00	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	29.61	8.46	0.71	1.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	2.24	0.56	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	69.26	15.13	1.59	1.59	0.80	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	41.45	5.44	0.00	0.68	0.00	0.34	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	27.29	6.17	1.95	0.97	0.00	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	23.78	6.39	0.71	0.00	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	39.49	7.90	15.79	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	14.14	0.98	1.46	0.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	2.48	1.49	0.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	3.28	0.94	0.47	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.87	8.28	1.32	0.99	0.66	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.68	5.26	0.62	0.93	0.00	0.62	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.29	6.73	2.14	0.31	1.22	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	17.11	1.74	0.63	1.43	0.32	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	20.86	6.10	1.12	2.41	0.48	0.32	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	26.46	3.69	0.64	0.89	0.38	0.13	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	12.71	3.74	0.75	4.48	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	18.76	2.01	1.34	1.34	0.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	10.85	0.64	0.00	3.19	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	5.50	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	8.58	0.90	1.81	1.35	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	14.08	1.91	1.39	1.74	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	41.07	6.06	1.76	0.98	0.59	0.20	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	45.56	9.01	1.80	2.57	0.26	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	33.73	13.94	2.23	0.28	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	49.96	11.76	0.59	0.59	0.00	0.00	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	40.94	7.56	1.45	2.01	0.40	0.08	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	44.22	10.65	1.61	2.90	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	33.59	6.40	3.20	1.60	0.53	0.00	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	6.68	1.67	0.56	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	24.95	7.90	1.25	4.99	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	27.63	6.03	0.75	1.00	0.25	0.50	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	30.76	8.51	0.98	0.65	0.00	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	24.05	8.53	0.61	1.52	0.30	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	25.41	9.72	1.99	2.21	0.22	0.22	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	19.72	9.32	5.38	2.15	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	9.58	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	23.93	3.96	2.34	2.34	0.36	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	6.69	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	17.87	6.78	3.90	1.44	0.41	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	21.28	2.98	1.14	1.83	0.46	0.57	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	19.10	6.12	0.73	1.71	1.22	0.24	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.62	5.39	1.80	2.70	0.00	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.23	3.47	2.60	2.60	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.73	3.29	2.39	0.60	0.60	0.30	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	3.79	0.00	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	10.56	1.98	0.00	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.94	3.90	0.65	2.27	0.00	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.50	2.43	2.43	2.43	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	12.47	1.78	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.59	3.39	1.88	2.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	5.81	0.00	2.18	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	3.76	0.00	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.51	3.79	1.15	1.15	0.49	0.00	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	4.09	2.73	2.73	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.48	2.11	0.45	0.15	0.15	0.45	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	3.75	1.61	1.61	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.34	3.78	2.65	1.89	0.38	0.00	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.77	2.67	1.07	1.60	0.27	0.00	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	2.93	0.00	2.93	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	2.16	1.16	1.66	0.50	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	1.20	0.00	1.20	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	11.66	3.26	1.37	1.37	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	0.97	2.91	1.94	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.00	2.28	1.14	2.28	0.38	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	4.85	3.63	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	14.25	1.14	0.57	2.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.61	2.57	1.50	0.21	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	0.77	1.03	0.77	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	1.41	0.47	2.35	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	13.83	3.22	2.89	0.96	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	1.43	0.71	0.00	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.87	4.09	1.75	0.58	1.17	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.74	2.41	1.81	0.90	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	0.00	1.19	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	2.54	1.02	2.54	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	4.08	0.76	0.51	0.25	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	0.64	0.64	1.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	17.69	2.16	0.86	2.59	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.31	1.69	1.48	1.91	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.73	1.16	1.16	0.87	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	3.78	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.94	2.88	2.03	1.53	0.17	0.34	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	4.23	4.23	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.87	1.50	0.86	1.07	0.00	0.00	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	17.45	3.01	1.80	2.41	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.77	3.64	0.73	2.92	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.49	2.99	0.46	1.38	0.69	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.92	1.02	1.02	1.02	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.86	3.30	0.83	1.65	0.62	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.63	2.75	0.31	1.53	0.00	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	2.87	0.96	2.87	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	14.86	2.66	0.89	1.33	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	1.11	1.11	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.86	1.85	1.85	1.85	0.00	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.90	2.18	1.09	1.45	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	59.69	6.14	2.09	1.97	0.37	0.37	0.37	0.25
Astrocyte - cerebellum, donor2	11580-120F5	52.55	9.41	3.77	2.57	1.03	0.51	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	45.93	4.40	1.26	1.05	0.00	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	51.24	6.27	1.74	1.74	0.35	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.53	10.19	3.40	1.94	0.65	0.32	0.00	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	63.99	12.53	1.94	1.64	0.75	1.04	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	71.11	41.86	5.50	4.24	0.57	1.26	1.95	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	61.01	44.98	7.89	4.64	0.75	0.63	3.38	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	62.02	44.49	9.10	3.76	0.34	0.91	2.39	0.34
Basophils, donor1	12241-129G9	48.38	7.32	1.05	2.88	0.26	0.52	0.00	0.26
Basophils, donor2	12242-129H1	52.68	13.35	1.08	2.16	0.72	0.36	1.08	0.00
Basophils, donor3	12243-129H2	25.28	6.61	2.06	3.53	0.15	0.00	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	9.06	2.80	2.37	0.65	0.22	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	8.69	5.49	3.20	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	5.02	9.41	6.28	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.89	14.35	4.99	3.12	0.00	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	8.06	8.52	3.22	1.84	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	9.54	7.74	1.26	0.90	0.36	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	59.88	20.92	1.85	1.75	1.24	0.52	1.34	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	88.50	23.76	2.79	2.33	2.10	0.00	0.70	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	75.15	11.19	2.88	3.52	0.00	0.32	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.14	11.83	2.25	6.76	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	58.46	16.89	4.45	8.35	0.37	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	50.49	12.73	3.73	4.61	0.22	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.04	7.64	2.55	1.13	0.00	0.00	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	27.29	7.96	1.14	1.52	0.00	0.00	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.27	8.22	1.64	1.64	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	39.03	8.09	4.77	3.90	0.00	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	30.17	6.94	2.72	1.51	0.00	0.00	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	47.14	8.77	5.69	4.26	0.00	0.00	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.62	5.69	2.01	2.34	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	6.07	2.21	1.93	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	23.80	6.20	2.98	3.97	0.00	0.00	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.71	4.11	1.37	0.98	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.34	3.20	1.60	2.14	0.18	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.41	2.61	0.87	2.39	0.87	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.28	4.92	0.94	1.17	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	16.37	8.98	3.17	1.58	0.00	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	3.33	4.44	2.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.95	5.95	2.08	1.64	0.15	0.00	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	17.96	5.79	1.80	2.20	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	18.32	4.79	0.62	2.71	0.62	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.87	3.89	1.83	2.52	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.67	4.98	0.90	1.36	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	13.09	1.75	0.87	0.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.82	10.49	2.42	3.23	0.54	0.00	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.18	8.03	2.62	2.09	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	35.77	8.84	2.10	3.79	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.15	4.23	0.73	1.29	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.78	4.93	3.52	2.47	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	18.43	3.51	2.63	4.83	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.68	5.06	1.39	1.22	0.00	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	3.72	3.35	1.86	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	19.40	6.04	1.29	1.94	0.86	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	15.97	5.32	0.82	2.46	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.38	3.94	0.00	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.15	2.55	0.46	1.39	0.46	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	14.17	6.97	2.62	1.09	0.22	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	19.40	7.39	2.08	3.70	0.00	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	16.03	6.50	2.38	2.38	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	31.61	9.03	3.43	4.67	0.00	0.31	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	21.31	7.16	2.62	4.72	0.00	0.00	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	33.00	13.38	3.12	4.46	0.22	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	9.95	7.40	2.81	4.34	0.26	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	10.54	6.37	2.85	3.29	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	11.16	6.53	1.47	1.68	0.21	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	12.19	4.06	0.00	2.03	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	71.19	27.80	5.42	2.71	4.07	2.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	69.39	17.61	4.14	4.14	2.07	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	129.00	18.12	4.26	5.86	1.07	2.13	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	103.46	22.51	6.43	8.04	1.61	3.22	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	88.44	18.25	2.81	6.32	0.00	2.11	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.08	14.90	3.92	1.57	0.00	3.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	89.64	10.55	5.27	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	270.41	32.88	8.22	7.40	0.00	3.29	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	196.59	30.47	6.53	8.71	0.73	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	226.16	25.75	6.56	7.07	0.00	2.52	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	28.28	52.53	6.46	4.04	3.64	0.81	1.62	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	19.18	42.75	4.79	5.19	3.20	0.40	1.60	0.00
CD34+ Progenitors, donor1	11545-120B6	69.28	4.02	0.00	1.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	117.42	10.67	1.12	4.49	0.00	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.84	10.90	1.13	1.88	0.00	0.38	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	48.25	15.11	1.58	0.90	0.68	0.45	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	268.51	23.57	6.78	8.93	0.00	2.14	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	295.16	26.33	7.35	10.41	1.84	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	159.21	23.48	6.40	7.01	1.22	1.83	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	88.57	18.63	3.57	4.08	1.02	3.57	0.77	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	86.25	17.07	2.70	3.59	0.45	4.27	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	96.30	14.95	3.16	6.61	0.00	2.87	1.72	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	168.78	15.65	2.37	5.22	0.47	1.42	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	159.43	20.37	2.81	2.81	0.70	2.11	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	207.66	32.96	9.89	3.30	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	65.61	14.02	3.03	4.77	0.29	4.34	0.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	60.84	18.13	6.95	6.10	0.68	3.22	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.84	20.80	5.48	4.67	0.48	2.42	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	134.94	11.66	2.24	4.48	1.34	5.38	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	128.57	11.18	2.45	6.64	0.70	5.59	1.05	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	182.15	17.60	3.08	7.04	2.64	7.48	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	89.39	18.97	2.53	2.95	0.42	0.84	1.69	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	39.27	18.28	5.61	4.57	0.00	0.83	1.25	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.76	16.37	4.01	4.34	0.33	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	187.91	18.49	4.35	5.71	1.36	1.63	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	206.88	24.65	8.04	6.43	1.07	1.61	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	168.56	28.69	5.38	12.55	0.00	3.59	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	73.99	21.14	5.93	6.30	0.56	1.67	0.56	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	55.45	15.60	3.25	4.98	0.87	1.30	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	61.99	16.60	2.73	4.41	0.63	2.94	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	134.49	14.66	2.53	9.10	1.52	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	124.78	17.76	5.63	7.37	0.87	3.03	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	104.16	18.30	3.49	3.49	1.31	2.18	0.87	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	114.81	23.26	5.44	3.96	0.99	1.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	69.24	18.46	0.00	4.62	3.69	5.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	61.42	25.12	1.40	6.98	2.79	1.40	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	148.99	19.11	4.43	5.54	0.83	2.22	0.83	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	107.48	21.10	3.68	5.15	0.74	2.70	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	124.74	36.96	1.54	7.70	1.54	1.54	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	78.07	17.19	2.51	3.22	0.72	3.94	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	72.02	26.31	4.15	5.54	2.77	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	150.60	18.66	4.58	6.88	0.65	1.64	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	156.56	23.65	4.13	6.01	0.38	0.75	0.38	0.00
CD8+ T Cells, donor3	11383-118B6	207.80	30.80	7.07	6.06	2.27	2.02	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.63	9.86	4.13	3.67	2.52	2.29	0.69	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	27.08	6.71	5.03	5.27	1.44	1.92	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	25.44	6.02	2.46	1.92	2.19	2.46	1.37	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.62	7.51	2.70	1.50	5.10	6.30	0.30	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	30.00	7.92	3.84	3.84	3.60	3.12	0.96	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.70	12.05	4.09	3.64	2.27	2.05	0.23	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	23.03	8.69	3.04	3.26	2.17	4.35	0.65	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	28.43	9.48	3.16	3.42	3.68	4.21	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	27.20	8.68	2.58	5.16	3.75	3.52	0.70	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.83	10.87	4.83	4.83	5.74	6.34	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	9.88	2.61	2.91	3.49	6.97	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.05	8.79	4.00	3.20	5.86	4.53	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	40.27	22.33	5.69	5.25	5.69	3.06	0.44	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	38.71	17.76	10.02	8.20	8.20	3.19	0.91	3.64
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	65.64	29.09	5.22	8.20	4.48	2.98	1.49	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.97	9.00	3.60	2.88	2.16	3.24	0.36	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	28.20	8.34	4.03	3.16	2.01	1.73	0.00	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	29.46	8.72	5.19	4.71	0.94	1.89	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	29.16	10.14	1.58	3.17	4.12	3.80	0.00	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	25.53	10.76	4.61	3.08	2.15	3.69	0.31	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.57	7.05	1.60	3.85	3.85	4.17	0.00	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.54	13.00	1.91	2.68	3.06	4.97	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.22	7.88	3.15	2.76	3.55	4.34	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	14.37	7.56	0.76	1.51	3.78	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.07	45.77	8.83	2.41	2.41	5.62	1.61	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	84.63	48.26	4.90	5.60	9.79	4.90	0.70	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	81.14	41.07	1.00	3.01	10.02	8.01	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	74.94	14.62	5.48	9.14	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	25.20	6.92	1.48	0.49	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	20.73	2.32	0.42	0.21	0.42	0.21	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	16.64	5.89	2.08	3.47	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	19.90	5.69	2.49	0.71	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	17.29	6.37	1.02	1.37	1.02	0.11	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	34.91	3.58	1.79	2.69	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.50	8.09	2.83	2.02	0.00	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	49.69	5.74	2.07	0.69	0.34	0.46	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	31.85	4.28	2.35	1.50	0.64	0.64	0.00	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	38.23	5.58	1.68	1.68	0.80	0.44	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	61.26	14.40	2.75	1.83	1.56	0.46	0.18	2.38
Corneal Epithelial Cells, donor1	11526-119I5	8.56	6.37	2.20	1.10	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	5.69	1.14	5.69	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.50	9.46	4.09	1.79	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.09	2.15	4.62	1.98	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.10	1.58	5.36	1.58	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	3.45	0.00	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.67	2.16	4.64	2.48	0.00	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.47	10.25	2.39	6.49	0.34	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	58.76	6.53	1.31	6.53	0.65	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	74.04	10.16	1.94	5.81	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	45.69	11.67	3.67	2.00	0.50	0.33	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	5.87	2.35	1.76	0.59	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	61.65	13.86	1.98	2.55	0.00	0.00	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	71.56	9.04	1.18	3.15	0.79	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	40.43	9.02	0.87	1.45	0.87	0.29	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	43.29	12.00	1.65	2.59	0.24	0.24	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	42.95	15.43	2.10	2.45	0.53	0.53	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	29.04	7.31	0.89	1.33	0.22	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	34.08	5.17	0.61	2.13	0.00	0.91	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	56.10	7.61	0.28	0.28	0.00	1.69	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	36.25	5.94	0.59	1.19	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	10.41	2.60	2.08	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	40.98	7.51	1.13	0.85	0.14	0.00	0.85	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	40.81	11.60	1.20	1.20	0.00	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	32.50	6.81	0.52	1.57	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	76.54	13.42	1.49	2.11	0.00	0.75	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	67.35	18.25	2.39	1.74	0.43	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.67	21.13	1.83	1.95	0.24	0.61	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	46.64	13.65	0.00	3.41	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	50.99	6.29	2.10	0.70	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	45.69	10.99	1.88	0.63	0.94	0.16	0.16	0.00
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	268.99	11.55	3.30	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	149.81	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.82	4.64	1.95	0.98	0.49	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	4.93	0.00	3.28	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.93	1.09	0.66	0.44	0.33	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.14	2.60	1.08	1.19	0.22	0.11	0.00	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.62	3.64	1.09	1.09	0.24	0.12	0.00	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.71	6.41	3.68	5.05	2.05	0.55	0.27	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.31	3.38	0.95	1.48	0.21	0.00	0.00	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	79.31	6.32	3.69	2.63	1.84	0.00	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.56	7.31	2.99	2.33	1.00	0.33	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	34.48	6.35	0.00	2.72	0.45	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	31.08	3.79	2.27	3.79	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.67	4.42	1.26	1.89	0.47	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	48.50	8.18	1.52	1.52	1.21	0.61	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	27.28	7.61	1.52	1.90	0.38	0.25	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	28.35	9.70	1.97	2.27	0.30	0.61	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	49.71	5.49	0.80	1.21	0.00	0.27	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	44.87	3.88	3.02	2.16	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	4.39	2.93	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	49.36	14.76	4.15	2.08	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	39.52	4.41	0.85	1.02	0.51	0.51	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	11.03	4.93	1.64	3.05	0.23	0.00	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	21.70	6.60	3.77	3.30	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	9.79	2.90	3.51	3.63	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	18.88	12.55	3.62	3.50	0.45	0.00	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	20.76	15.18	6.28	4.36	0.87	0.52	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	27.12	15.27	3.74	4.55	0.32	0.16	0.16	0.00
Fibroblast - Gingival, donor1	11237-116D4	19.16	5.21	1.87	1.87	0.42	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	53.45	7.34	2.88	2.62	0.26	0.52	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	25.04	7.78	3.69	3.43	1.05	0.40	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	29.78	9.77	2.22	2.51	0.39	0.00	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	19.74	5.19	3.12	0.00	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	28.02	6.34	2.29	3.00	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	55.81	9.98	4.52	9.04	1.71	0.31	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	33.13	5.00	3.52	5.41	1.08	0.41	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	119.27	23.64	3.88	2.82	0.35	0.00	0.35	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	43.43	7.75	2.78	4.24	0.88	0.58	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	45.00	5.59	2.86	3.82	1.09	0.55	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	53.20	9.21	4.72	7.13	0.88	0.66	0.22	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	62.95	8.51	1.32	2.35	0.44	0.29	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	16.31	4.08	4.08	2.72	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	10.45	4.48	5.97	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	20.26	5.91	3.17	1.69	0.21	0.21	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	10.00	5.00	4.17	1.67	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	4.20	5.59	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	13.71	4.20	1.40	1.96	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	24.76	9.34	3.65	3.65	1.62	1.22	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	19.97	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.11	9.31	2.72	2.91	0.97	0.78	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.93	15.77	4.70	5.01	0.76	0.30	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.03	4.59	1.84	3.67	1.53	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	44.65	6.87	2.67	1.53	0.38	0.38	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	21.06	7.02	2.70	3.24	1.62	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.09	10.90	2.09	2.67	0.70	0.00	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	20.34	5.64	1.22	1.22	0.44	0.33	0.11	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.09	8.74	6.30	4.47	0.81	0.20	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.07	6.01	4.68	5.35	0.67	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	3.95	3.56	1.19	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	90.49	10.91	5.95	7.54	0.60	0.20	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	19.54	5.51	0.71	1.07	0.36	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	22.66	4.53	1.97	1.97	0.00	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	49.94	8.42	5.11	5.42	0.60	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.28	4.53	2.48	2.70	0.11	0.00	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	52.39	8.10	4.56	2.28	1.01	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	19.69	3.77	2.46	1.80	0.33	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.69	10.03	5.21	6.42	1.20	0.80	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	29.13	5.73	2.01	2.71	0.60	0.30	0.20	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	76.47	9.67	3.63	8.76	1.21	0.91	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	28.50	4.47	0.83	1.08	0.33	0.17	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	43.42	3.42	1.03	0.68	0.85	0.51	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	59.12	8.54	2.96	4.60	1.64	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.48	4.69	2.56	3.52	0.85	0.11	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	28.17	5.90	3.04	2.53	1.52	0.67	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.90	4.08	0.47	1.41	0.31	0.00	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	6.97	6.97	6.10	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	5.89	3.47	2.08	1.73	0.17	0.17	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.59	4.94	4.16	1.04	0.26	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	8.18	6.39	3.58	1.53	0.00	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	14.55	0.77	0.77	0.00	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	28.08	8.29	0.00	0.64	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	30.81	11.13	0.29	0.57	0.00	0.00	0.57	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	158.56	30.88	1.38	3.58	0.00	0.00	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	116.45	20.32	1.37	2.74	0.46	0.23	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	36.65	17.44	0.99	0.99	0.00	0.40	0.20	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	116.84	31.19	0.53	1.59	0.26	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	89.69	22.50	2.94	1.30	0.65	0.33	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	27.42	15.92	0.44	0.00	0.44	0.00	0.88	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	16.96	7.63	0.57	0.14	0.28	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	33.74	8.37	0.62	0.49	0.12	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.48	9.40	0.27	0.00	0.00	0.00	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.89	8.42	0.37	0.87	0.74	0.25	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	29.90	7.61	0.55	0.83	0.28	0.00	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	6.51	0.61	0.61	0.00	0.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	52.02	7.99	0.91	0.46	0.00	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.63	4.86	0.50	0.25	0.50	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	28.41	5.68	0.87	0.22	0.22	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.16	5.61	0.59	1.18	0.00	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	55.48	8.74	0.48	0.64	0.16	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	34.63	6.48	0.89	0.22	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	71.78	7.86	2.42	1.01	0.20	0.20	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	64.29	8.99	1.70	0.51	0.00	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	61.36	8.51	1.51	0.71	0.35	0.09	0.09	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	115.09	7.28	1.66	0.52	0.31	0.10	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	107.93	7.00	1.02	0.17	0.34	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	66.95	9.07	1.99	1.99	0.33	0.11	0.00	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.99	8.40	1.00	0.67	0.08	0.08	0.08	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.09	7.35	1.02	1.43	0.41	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	65.40	8.66	0.00	0.21	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	76.55	9.22	1.04	0.58	0.12	0.12	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	66.54	11.17	1.17	0.17	0.17	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	70.54	7.27	0.44	0.66	0.44	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	76.38	8.12	1.60	0.49	0.25	0.00	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	68.73	11.02	1.46	0.97	0.32	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	94.93	7.70	0.64	0.96	0.00	0.64	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.23	5.59	1.14	1.14	0.47	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	58.37	8.38	1.58	1.58	0.32	0.00	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	76.02	12.77	3.04	0.91	0.00	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	58.12	6.69	1.57	0.94	0.52	0.10	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	56.43	7.68	0.44	0.00	0.00	0.00	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	70.42	6.73	1.12	0.84	0.00	0.00	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.00	5.83	2.78	2.41	0.46	0.09	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	40.11	7.22	2.14	1.60	0.00	0.00	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	46.97	7.96	3.52	1.84	0.46	0.31	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.01	5.96	1.81	2.72	0.39	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.35	7.86	1.08	0.81	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.93	5.90	1.84	0.55	0.18	0.18	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	54.17	4.17	1.54	1.75	0.44	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	93.22	13.88	0.00	0.99	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	42.48	4.09	1.85	1.32	0.40	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	39.34	2.82	2.42	1.21	0.00	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	85.65	3.81	0.25	1.27	1.02	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	11.74	8.36	0.00	0.20	0.00	0.00	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.25	5.55	0.31	0.15	0.00	0.00	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	18.00	9.82	0.20	0.00	0.20	0.20	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	21.28	9.70	0.00	0.31	0.00	0.00	0.00	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.71	5.93	0.28	0.00	0.28	0.00	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	27.21	8.30	0.46	0.00	0.00	0.00	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	14.85	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	30.94	10.06	1.16	1.55	0.77	0.00	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	17.65	0.00	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	6.96	0.00	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	43.29	10.09	0.33	0.00	0.00	0.00	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.89	13.18	1.24	0.41	0.82	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	16.66	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	9.79	0.56	0.56	0.56	0.00	0.28	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.39	13.07	0.98	1.31	0.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	18.45	0.00	0.00	0.00	0.00	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	66.48	16.22	1.91	0.95	0.32	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	58.42	12.23	0.68	1.36	0.34	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	14.62	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	71.01	16.04	0.57	0.57	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	36.11	9.77	0.30	0.89	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	45.74	15.25	0.00	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.40	10.36	0.83	2.07	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.67	9.67	1.15	0.92	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	21.07	0.00	0.00	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	48.44	11.53	0.38	0.38	0.00	0.00	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	45.31	9.45	1.63	0.98	1.30	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	64.88	10.03	0.67	0.67	1.34	0.67	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	83.22	12.71	0.77	0.77	0.39	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	92.09	17.46	2.74	3.08	0.34	0.00	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	109.33	14.91	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	83.99	13.68	0.94	0.94	0.47	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	67.59	11.47	0.60	0.00	0.00	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	100.21	19.84	2.03	0.51	0.51	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	84.15	8.38	0.80	0.00	0.40	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	81.40	10.36	2.47	0.00	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	93.25	17.71	2.36	1.18	3.54	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.35	8.17	1.17	0.58	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	77.68	10.53	0.00	0.00	0.44	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	113.59	5.09	0.00	0.00	0.00	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	65.06	9.55	1.79	1.19	0.60	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.60	5.82	1.46	2.43	0.00	0.49	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	3.42	2.28	3.42	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.87	4.99	2.91	3.74	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	23.61	7.87	0.00	6.75	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.66	2.22	1.27	0.63	0.00	0.95	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	6.68	2.92	0.00	1.67	0.84	0.00	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.98	9.28	4.29	2.55	0.46	0.12	0.81	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	32.92	8.95	3.54	3.54	0.34	0.00	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	25.25	9.33	5.01	4.10	1.59	0.23	0.23	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	33.89	8.53	5.36	2.73	0.87	0.11	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.44	9.24	4.08	3.65	0.64	0.43	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.47	9.90	5.38	2.37	0.00	0.43	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.03	7.72	4.36	2.12	1.00	0.12	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.13	6.69	5.15	2.74	0.86	0.00	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.79	8.97	3.84	2.88	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	64.92	10.63	0.56	1.12	0.00	1.12	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	40.25	9.95	3.90	1.30	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	50.79	7.05	1.41	1.76	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	3.63	0.73	1.45	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	17.48	7.17	1.57	1.05	0.52	0.17	0.52	0.00
Hepatocyte, donor1	11523-119I2	38.74	15.74	3.63	3.63	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	44.17	12.93	5.39	10.77	1.08	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	44.17	22.70	2.45	2.45	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	243.45	48.30	9.14	12.40	1.96	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	105.92	18.88	3.85	2.10	1.05	0.17	0.52	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.17	3.43	0.82	0.69	0.27	0.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	76.41	50.94	3.18	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	60.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	27.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	71.99	31.84	5.54	2.77	0.00	0.00	2.77	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	42.55	2.50	5.01	0.00	0.00	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	35.60	0.00	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	92.26	25.63	0.00	0.00	2.56	0.00	0.00	7.69
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	18.28	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	73.09	29.24	4.87	1.62	1.62	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	68.36	25.01	5.00	0.00	3.33	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	25.41	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	43.67	3.97	3.97	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	69.84	35.48	6.65	2.22	0.00	0.00	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	41.91	0.00	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.80	24.56	2.52	1.89	2.52	0.00	0.00	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	61.86	30.93	6.19	1.55	0.00	0.00	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	79.46	33.59	3.88	1.29	0.65	1.29	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	45.08	4.83	1.61	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	71.69	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.08	32.60	4.89	2.44	1.63	0.00	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	72.63	27.71	2.52	3.36	0.00	0.42	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	67.51	27.33	1.61	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	50.78	39.70	2.77	3.69	0.00	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	47.20	23.60	3.78	0.94	0.00	1.42	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	34.47	23.58	3.63	0.91	0.91	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	59.19	33.36	4.30	1.08	0.00	0.00	2.15	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	63.52	44.47	8.89	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	49.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	63.13	42.09	7.01	1.28	0.00	0.00	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	71.08	32.81	3.65	5.47	0.00	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	52.84	28.56	5.71	0.71	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	29.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	39.82	23.77	6.17	1.85	0.62	0.62	0.62	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	59.70	31.61	3.51	3.51	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	40.86	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.11	30.60	4.17	1.39	0.00	0.00	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	53.11	2.21	2.21	2.21	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	35.66	0.00	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	48.83	38.36	4.36	2.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	74.24	47.25	11.25	2.25	0.00	0.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	48.78	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	60.81	39.47	2.13	3.20	0.00	1.07	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	73.43	23.55	4.16	1.39	2.77	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	94.04	48.44	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	60.75	46.94	5.52	0.00	2.76	0.00	0.92	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	51.43	75.63	3.03	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	80.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	54.98	43.35	3.17	0.00	1.06	0.00	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	13.14	3.84	2.37	1.63	0.16	0.08	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	6.44	7.03	4.69	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.84	7.38	4.45	1.89	0.47	0.09	0.00	0.19
Keratinocyte - oral, donor1	11251-116E9	15.78	9.42	2.95	1.25	0.11	0.11	0.00	0.11
Keratocytes, donor1	11527-119I6	28.19	6.88	1.72	1.72	1.03	0.00	0.34	0.34
Keratocytes, donor2	11607-120I5	18.75	12.89	4.69	5.86	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	28.06	7.31	0.79	1.19	0.20	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	46.16	4.40	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	22.65	2.16	3.24	0.00	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.37	4.73	0.58	0.69	0.92	0.12	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	30.78	2.52	1.01	1.41	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	36.17	7.23	1.07	0.71	0.00	0.24	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	27.63	6.70	1.40	1.95	0.00	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.88	9.60	2.52	0.79	0.16	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	4.30	0.54	0.00	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	45.38	6.93	0.63	1.58	0.00	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	32.67	6.47	1.19	1.08	0.32	0.00	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.88	7.80	0.00	0.41	0.41	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	32.61	7.58	2.02	0.76	0.00	0.76	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.03	6.90	0.70	1.41	0.14	0.14	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	31.64	8.31	0.40	0.40	0.00	0.40	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.16	8.72	1.74	0.58	0.39	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.70	4.44	1.30	1.48	0.00	0.19	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	32.75	8.71	0.00	0.35	0.00	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	37.93	6.68	1.43	0.00	0.00	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.45	7.42	0.96	1.65	0.41	0.27	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	34.18	8.62	0.31	0.92	0.31	1.23	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.81	4.68	1.56	2.18	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	38.98	8.23	1.28	0.37	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.18	6.58	0.33	0.66	0.99	0.33	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	35.73	7.91	0.29	0.88	0.00	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	42.32	7.47	0.50	1.00	0.25	0.50	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.61	7.27	0.00	0.48	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.62	7.54	1.89	0.27	0.00	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.73	8.48	1.06	1.06	0.15	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	6.74	0.52	0.00	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	41.67	7.33	1.47	1.47	0.21	0.63	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.59	6.92	0.90	1.05	0.00	0.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.77	13.07	0.00	0.69	0.00	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	37.25	8.84	0.94	0.56	0.75	0.19	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	34.35	5.83	1.17	1.27	0.11	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	38.77	8.24	0.48	0.48	0.00	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	37.38	6.95	0.99	1.32	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.96	6.94	2.35	1.36	0.00	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	54.42	7.40	0.74	0.37	1.11	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.67	5.19	1.24	0.74	0.00	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	32.86	7.56	0.55	2.06	0.27	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	31.52	8.04	0.00	0.96	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.61	6.70	0.61	2.43	0.30	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.45	7.28	0.84	1.54	0.70	0.42	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	33.42	6.04	0.36	1.42	0.00	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	42.66	8.24	0.97	0.97	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.06	6.85	1.09	1.71	0.16	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.65	7.52	0.00	0.72	0.36	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	45.08	12.09	2.29	1.31	0.98	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	36.26	6.12	0.94	1.65	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.40	8.54	0.25	0.12	0.25	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	46.87	7.94	1.54	1.54	0.00	0.00	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.31	4.77	1.19	1.49	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	4.53	2.27	2.27	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	39.89	6.14	2.30	3.84	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	35.63	4.45	0.74	0.00	2.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	53.31	4.23	4.65	1.27	0.85	0.42	0.00	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.06	5.63	2.11	2.11	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	2.80	2.80	3.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	42.25	3.61	1.55	0.52	0.52	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	3.57	1.19	0.00	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	30.99	4.30	2.49	1.58	0.45	0.00	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.21	5.23	1.45	0.58	0.29	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	22.51	3.60	4.05	0.90	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.41	4.20	2.30	1.90	0.68	0.27	0.14	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	3.59	2.05	0.51	0.51	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.35	3.18	3.18	1.06	0.00	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.32	4.66	1.33	2.67	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	44.32	6.62	1.53	3.06	0.00	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	29.62	5.07	1.87	1.87	1.33	0.27	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	28.53	4.91	2.65	0.94	0.19	0.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	47.24	4.29	6.14	3.68	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.93	6.52	3.26	2.45	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	29.99	6.46	3.12	2.29	0.42	0.62	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.51	2.80	3.92	3.36	0.00	0.00	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	41.21	7.21	1.03	5.15	2.06	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.03	4.94	2.32	2.32	0.58	0.00	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.81	3.59	2.09	2.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	23.79	6.09	2.21	2.77	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	43.48	3.18	4.60	3.89	0.35	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.04	5.90	2.21	1.11	1.48	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	27.63	3.45	3.45	2.30	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	37.22	7.29	3.45	3.45	1.54	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	36.23	3.96	3.96	2.26	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	28.72	6.56	4.10	0.82	0.82	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	37.96	3.16	2.26	1.81	1.81	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	42.37	4.31	3.59	0.72	0.72	1.44	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	36.60	4.48	3.73	1.49	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	39.39	3.72	4.09	1.49	0.37	0.37	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	3.88	0.86	3.02	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	28.26	6.85	1.71	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	37.65	6.33	2.33	2.33	0.33	0.00	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	48.26	3.62	0.60	0.60	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	4.98	1.42	2.13	2.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	39.18	4.81	3.44	1.03	1.72	0.69	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	43.48	2.68	1.61	2.15	1.61	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	32.32	4.71	3.37	1.35	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	42.97	5.19	4.07	0.74	1.11	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	50.01	5.81	1.16	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	33.85	3.17	2.12	1.06	1.06	1.06	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	37.61	6.80	3.60	2.40	0.80	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	56.70	10.18	2.91	0.73	2.18	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	6.90	6.13	0.77	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	50.81	7.89	1.97	1.97	0.99	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	50.81	3.76	1.88	3.76	0.00	0.00	0.94	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	42.24	7.54	4.53	2.01	2.01	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	40.56	3.60	2.70	2.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	72.29	1.72	1.72	1.72	0.00	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	47.21	8.46	2.23	0.89	2.23	0.45	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.05	6.26	1.96	1.17	0.78	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	56.74	7.92	2.64	1.32	0.66	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	40.48	9.34	2.59	1.04	2.08	0.00	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	54.70	8.31	3.94	4.81	2.63	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	44.17	3.35	4.47	2.24	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.07	5.74	3.53	3.09	1.77	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	41.27	6.94	3.09	3.86	0.77	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	43.55	6.08	4.56	3.04	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.89	5.77	5.77	1.92	0.00	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	38.56	4.37	4.37	1.19	1.19	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	43.75	7.29	2.43	6.68	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	38.04	7.61	4.84	2.08	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	37.24	6.84	3.42	4.56	0.38	0.38	0.38	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	39.25	3.10	7.23	2.07	2.07	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.79	7.86	3.02	1.81	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	36.13	4.75	3.49	2.54	0.63	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	25.06	5.33	2.67	1.07	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.03	5.75	5.75	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.54	5.14	6.17	2.57	1.54	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	41.73	2.83	2.83	6.37	1.41	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	31.78	4.54	3.97	3.97	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.45	7.90	2.50	2.50	0.42	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	29.76	5.48	1.57	0.78	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.48	6.26	3.34	2.51	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	30.67	4.18	1.86	3.72	0.93	0.46	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.09	3.35	2.68	1.34	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.59	3.21	4.81	1.60	2.14	0.00	1.07	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	23.44	5.25	4.04	1.62	1.21	0.81	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	30.29	7.34	5.51	1.84	0.92	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	45.34	3.56	4.45	4.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	30.77	4.56	3.99	1.71	0.57	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	42.18	5.37	3.83	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	37.76	2.74	4.38	1.64	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	30.29	7.13	4.45	1.34	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.09	2.34	2.34	1.56	0.78	0.26	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	34.48	3.32	3.98	1.33	1.99	0.00	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	4.16	8.31	6.24	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	7.29	6.84	2.73	2.05	0.23	0.46	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	3.30	2.75	3.30	2.39	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	8.78	6.95	4.19	3.15	0.00	0.13	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.59	3.19	1.59	1.06	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.88	4.44	1.74	1.90	0.16	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	10.42	5.00	3.20	2.08	0.28	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	8.97	8.07	1.89	1.49	0.10	0.00	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	8.40	8.69	2.32	1.16	0.87	0.00	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	14.47	7.98	4.99	3.24	1.50	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	7.46	1.36	1.36	0.00	0.68	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	12.33	6.70	3.35	1.95	0.11	0.43	0.32	0.00
Mast cell, donor2	11565-120D8	42.79	11.59	2.38	2.38	1.49	0.59	0.00	0.00
Mast cell, donor3	11566-120D9	50.88	11.26	1.80	2.70	1.13	0.68	0.45	0.45
Mast cell, donor4	11567-120E1	42.02	14.36	2.48	3.90	0.53	0.89	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	13.31	6.43	3.11	1.66	0.11	0.11	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	28.60	9.34	4.67	4.67	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	7.80	7.34	1.61	0.57	0.00	0.23	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	42.51	13.89	3.01	2.34	0.33	0.17	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	36.81	6.57	0.90	1.29	0.70	0.40	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	29.42	10.04	1.73	1.38	0.00	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	27.82	7.24	2.46	2.75	0.65	0.07	0.14	0.07
Melanocyte - light, donor1	11274-116H5	46.31	7.29	1.88	2.35	0.47	0.47	0.24	0.00
Melanocyte - light, donor2	11351-117H1	51.18	6.82	5.46	1.36	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	23.42	6.07	3.47	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	32.38	6.46	2.39	1.67	0.21	0.21	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	30.12	4.57	1.61	3.23	0.54	1.88	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	51.43	10.18	1.87	2.14	1.07	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	68.73	10.67	2.23	2.11	0.74	0.25	0.12	0.50
Meningeal Cells, donor2	11573-120E7	68.66	11.44	1.76	2.20	1.32	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	39.12	5.54	2.69	1.71	0.41	0.33	0.33	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	21.10	4.28	2.57	3.14	1.14	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.09	3.12	2.11	1.21	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	3.94	2.63	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	10.47	5.23	2.62	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	6.46	4.31	2.87	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.99	2.12	0.42	1.48	1.27	0.64	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	26.64	6.03	1.51	1.51	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	23.51	5.93	1.32	3.74	0.88	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.73	6.58	2.92	3.65	0.73	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	20.26	7.37	3.27	5.12	0.82	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.70	3.60	0.55	1.66	1.11	0.14	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	21.93	4.09	0.74	1.49	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.79	5.00	0.66	1.18	0.13	0.00	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	3.56	0.30	0.59	0.30	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	7.01	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	26.26	9.61	1.92	1.28	2.56	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	8.15	8.15	3.90	2.48	0.00	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.14	3.13	0.31	0.31	0.63	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	8.71	4.35	2.90	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	14.05	2.65	1.86	1.86	0.00	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	13.51	2.00	1.00	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	19.01	4.48	1.08	1.08	0.36	0.07	0.22	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	10.80	4.05	9.45	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.87	4.19	4.43	3.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.01	3.53	2.65	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	6.91	17.29	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.51	3.72	2.79	2.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.15	1.87	3.32	3.73	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	11.58	16.21	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.01	4.50	3.75	0.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	7.91	4.65	4.19	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	19.47	0.00	0.00	0.00	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.35	3.86	3.45	2.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	3.56	3.96	2.77	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	3.54	0.88	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.56	2.28	3.42	3.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	7.90	3.95	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.40	2.97	1.49	1.70	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.92	5.52	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.58	3.58	1.49	1.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	5.03	8.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.77	4.27	4.27	1.76	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.52	2.85	2.85	1.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.29	11.06	4.42	7.19	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.84	2.99	3.22	1.38	0.00	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.00	3.37	2.52	2.31	0.21	0.21	0.63	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.52	3.87	3.06	1.83	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	2.57	1.50	1.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.22	1.78	2.45	1.33	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.57	3.29	2.85	2.19	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	4.56	4.06	5.58	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	4.97	3.31	4.97	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	4.62	5.98	4.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.65	2.35	2.06	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	7.63	3.27	4.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	4.81	1.92	2.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.20	1.20	3.60	2.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	9.60	4.11	4.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	1.50	3.50	2.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	4.08	8.15	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	5.26	4.38	1.75	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	3.31	4.41	2.21	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.09	8.33	7.68	5.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.16	4.96	4.96	3.47	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	2.09	9.05	2.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	4.42	15.47	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.18	3.76	3.76	4.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	4.38	2.19	8.31	3.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	6.75	6.04	11.72	0.00	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.14	5.05	3.93	2.81	0.00	0.56	0.00	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	1.66	5.82	2.49	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	5.24	5.83	2.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.45	2.41	3.62	3.02	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	2.09	1.67	3.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	14.44	0.00	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.01	1.85	4.62	3.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	4.55	4.55	9.11	2.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.47	5.80	3.32	2.76	0.14	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.77	3.11	4.15	1.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	4.72	3.86	5.15	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.15	10.16	3.18	4.45	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.81	4.80	5.07	2.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.37	5.09	3.89	1.20	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.29	6.78	4.24	2.54	0.14	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.83	7.33	2.23	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.20	3.10	5.31	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.62	7.20	3.03	3.41	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.35	3.41	3.41	1.70	0.28	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	6.39	1.72	4.67	3.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	19.55	10.43	7.17	2.61	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	3.53	3.82	2.94	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	8.07	4.90	7.50	7.78	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.78	5.36	3.71	0.82	0.41	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.32	4.17	2.38	1.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	0.00	5.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.89	8.21	2.63	1.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	4.21	2.10	3.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.54	2.77	1.98	0.79	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	8.38	8.38	3.73	1.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.13	6.38	0.38	3.00	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	5.06	1.07	1.86	1.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	6.79	5.99	1.92	1.58	0.00	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	2.21	2.21	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	6.96	8.43	2.56	0.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	4.67	3.11	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	5.34	2.67	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	11.59	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	5.05	1.01	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.64	2.53	3.37	0.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	5.45	4.09	2.72	2.72	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.09	8.27	3.18	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	14.58	4.86	2.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	6.04	9.06	9.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	0.00	5.71	11.42	51.39	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	3.26	9.79	32.62	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	0.00	4.75	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	25.10	0.00	37.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.48	3.45	0.65	0.43	0.43	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.06	1.05	1.57	1.57	1.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	1.33	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.36	4.17	1.67	3.34	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	42.02	12.74	2.28	1.52	0.00	0.00	0.57	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	4.79	11.17	7.98	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.84	1.36	1.36	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	106.58	12.86	12.86	9.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.00	6.28	0.84	0.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	16.27	8.14	0.46	1.39	0.70	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	36.48	3.24	0.54	1.35	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	41.42	11.14	2.31	1.47	0.00	0.00	0.00	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	22.27	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.83	5.46	0.00	1.49	0.50	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.71	5.68	1.08	1.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.49	1.36	1.13	0.91	0.00	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	27.92	5.55	1.31	1.14	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	39.55	4.01	1.64	1.09	0.36	0.00	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	35.54	2.12	0.53	1.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	3.60	0.60	1.20	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	79.42	10.17	0.98	0.33	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.75	5.85	0.81	1.14	0.16	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	49.56	9.70	2.12	2.29	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	3.52	0.70	1.41	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	32.64	5.52	0.46	0.92	0.00	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.89	4.50	1.29	0.00	0.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	45.87	9.66	1.03	1.38	0.69	0.69	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	333.75	22.76	0.00	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	47.90	8.02	2.23	3.79	0.45	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.05	2.54	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	27.53	6.65	0.47	0.95	0.00	0.47	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	22.75	2.58	1.29	0.43	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	27.08	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	33.99	3.67	0.33	0.67	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	48.24	8.57	1.35	1.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	2.78	0.40	0.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	5.57	1.86	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.24	2.27	0.00	0.00	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.86	3.91	1.63	1.63	0.00	0.65	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	37.91	1.74	1.74	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	34.83	3.62	4.07	0.90	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	2.65	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.95	2.66	1.99	0.66	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.31	2.48	0.50	0.00	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.14	2.30	0.77	1.15	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	4.84	1.51	0.91	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	37.13	5.97	1.99	1.11	0.66	0.44	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	4.74	0.68	2.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	5.11	5.11	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.61	3.66	1.22	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.72	3.15	0.94	0.94	0.31	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	30.87	6.96	0.61	0.61	0.00	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	17.41	4.75	1.58	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	69.15	7.94	4.53	2.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	136.56	10.12	0.00	0.00	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	9.32	2.98	0.99	1.86	0.99	0.37	0.12	0.12
Myoblast, donor2	11322-117D8	23.78	3.07	3.26	2.88	0.77	0.77	0.19	0.00
Myoblast, donor3	11398-118D3	14.63	3.36	1.85	2.02	0.34	0.50	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	25.25	34.59	2.48	1.90	0.44	0.44	1.02	0.15
Natural Killer Cells, donor1	11230-116C6	119.62	11.99	2.77	2.46	0.92	0.62	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	143.84	16.89	4.22	6.33	0.90	0.90	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	143.56	21.17	2.94	5.89	0.37	1.10	0.00	0.00
Neural stem cells, donor1	11275-116H6	116.50	11.25	1.81	5.08	0.73	0.73	0.73	0.00
Neural stem cells, donor2	11352-117H2	96.28	9.63	1.93	3.85	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	88.76	6.83	3.41	1.14	0.00	1.14	0.00	0.00
Neurons, donor2	11574-120E8	53.50	7.05	1.32	1.98	0.00	0.22	0.22	0.22
Neurons, donor3	11655-122E8	47.69	13.15	7.40	0.00	1.64	1.64	0.82	0.00
Neutrophils, donor1	11233-116C9	101.15	4.64	0.93	1.86	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	69.57	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	106.29	5.50	0.61	3.05	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	38.23	4.27	0.47	0.83	0.24	0.12	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	22.47	4.88	1.95	0.65	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	20.46	6.62	0.80	1.20	0.60	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	22.16	3.72	1.10	2.34	0.28	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	18.53	3.18	2.46	3.76	1.30	0.14	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	21.34	3.86	0.91	2.04	0.45	0.00	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	38.57	3.99	2.43	2.63	0.58	0.19	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	19.26	3.61	1.81	2.41	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	23.18	4.47	0.85	0.64	0.43	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	9.14	3.43	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	2.48	2.48	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	42.21	2.15	1.76	1.76	0.98	0.20	0.39	0.39
Osteoblast, donor2	11354-117H4	29.50	5.62	2.11	1.40	0.70	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	29.33	4.98	3.73	3.20	0.71	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	20.55	3.62	1.85	2.44	0.25	0.17	0.00	0.00
Pericytes, donor1	11491-119E6	33.27	2.89	0.67	0.78	0.22	0.22	0.33	0.00
Pericytes, donor2	11571-120E5	29.65	2.26	0.68	1.58	0.00	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	31.74	8.75	3.46	2.85	0.41	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	29.50	5.99	1.13	0.68	1.36	0.45	0.11	0.11
Perineurial Cells, donor2	11579-120F4	30.64	6.16	1.29	1.47	0.64	0.37	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	130.68	17.85	4.14	3.82	0.64	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	86.19	16.16	3.92	5.14	0.24	0.49	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	89.94	18.64	2.72	4.79	0.65	0.78	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	18.18	4.78	1.67	1.43	0.48	0.00	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	14.42	4.44	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	26.70	5.10	0.59	0.79	0.00	0.20	0.00	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	8.86	0.63	0.95	0.95	0.32	0.00	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	17.26	3.00	0.56	1.88	0.38	0.00	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.84	6.66	1.31	3.65	1.31	0.13	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	12.16	6.30	1.80	1.80	0.45	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	27.92	2.98	1.07	1.17	0.00	0.00	0.00	0.11
Preadipocyte - omental, donor2	11329-117E6	17.02	5.24	1.75	1.75	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	19.20	4.44	0.29	1.29	0.57	0.14	0.14	0.00
Preadipocyte - perirenal, donor1	11469-119C2	19.69	5.91	1.97	0.00	0.98	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	13.51	2.76	3.07	4.61	0.31	0.31	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	15.76	4.96	6.20	5.14	0.53	1.24	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	15.16	4.60	2.89	3.41	0.51	0.17	0.00	0.00
Preadipocyte - visceral, donor1	11280-116I2	22.36	5.31	2.79	3.17	0.37	0.75	0.00	0.00
Preadipocyte - visceral, donor2	11357-117H7	20.71	6.44	1.84	2.30	0.00	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	11.91	6.37	3.13	3.76	0.84	0.73	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	108.16	14.93	1.66	1.66	1.21	0.75	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	11.10	3.52	2.17	1.08	0.00	0.00	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	10.23	3.61	1.22	0.49	0.00	0.00	0.12	0.00
Prostate Stromal Cells, donor1	11254-116F3	21.41	4.21	1.48	3.08	1.25	0.34	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	26.36	6.45	2.51	3.23	0.54	0.72	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	23.57	3.44	0.83	1.77	0.42	0.31	0.00	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.26	13.14	4.01	0.73	0.36	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	19.89	7.49	1.39	1.18	0.14	0.14	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	28.40	11.67	3.04	1.52	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	30.59	12.80	0.71	2.85	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	32.82	9.95	1.59	1.27	0.21	0.00	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	40.17	12.26	1.36	2.04	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	28.84	9.97	1.35	1.62	0.13	0.27	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	49.73	8.21	2.00	3.55	0.22	0.44	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	41.26	7.99	3.99	1.33	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	33.89	5.94	1.54	1.98	1.10	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	43.89	6.90	2.51	2.51	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	29.41	4.44	2.22	1.11	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	23.08	8.86	4.29	1.61	0.54	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	11.81	5.48	3.37	2.95	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	37.80	8.68	4.05	1.93	0.39	0.19	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	20.22	11.15	2.59	1.30	0.26	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	50.31	9.38	0.85	0.28	0.85	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	20.58	8.23	3.09	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.60	5.02	0.25	0.75	0.00	0.00	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	48.91	11.49	1.20	1.87	1.34	0.27	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	116.14	16.97	2.68	1.79	0.00	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	126.59	13.21	1.65	1.10	0.55	1.65	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	180.98	19.72	4.64	4.64	0.00	0.58	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	124.56	15.21	3.90	2.99	1.30	0.52	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	97.22	18.67	5.06	3.08	0.60	0.00	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	101.50	15.50	4.57	3.23	0.78	0.33	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	86.09	15.38	4.09	3.47	1.74	0.62	0.50	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	83.68	16.43	3.26	2.91	0.82	0.93	0.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	128.51	23.81	6.24	5.55	1.62	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	95.70	16.29	3.15	4.11	0.41	0.41	0.68	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	90.31	16.79	4.24	4.84	0.91	0.30	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	104.11	18.28	2.15	3.76	1.08	0.18	0.54	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	96.40	18.08	3.44	3.44	1.15	0.00	0.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	79.41	13.31	3.22	1.93	0.75	0.21	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	111.96	21.91	7.30	2.88	1.11	0.44	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	133.63	18.16	4.40	3.82	0.96	0.76	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	101.45	21.15	5.59	3.63	0.84	0.28	0.19	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	142.43	18.98	2.82	3.01	0.75	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	125.14	23.75	7.56	5.97	1.33	0.13	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	109.02	21.32	5.65	3.41	0.68	0.19	0.19	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	111.90	17.19	6.49	2.67	1.91	0.38	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	107.43	17.73	4.70	4.38	1.28	0.00	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	116.33	17.66	3.08	3.64	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	108.01	20.00	4.79	4.44	1.20	0.51	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	111.59	23.34	6.75	6.38	0.36	0.00	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	89.52	16.43	4.91	3.92	0.74	0.12	0.74	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	102.62	20.55	5.51	3.90	0.94	0.40	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	101.19	16.98	5.66	2.36	0.94	0.24	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	97.82	19.25	3.77	3.77	0.79	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	102.19	23.62	7.48	5.14	0.47	0.23	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	76.10	17.00	5.39	3.11	0.83	0.41	0.41	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	128.97	27.87	4.20	3.10	0.22	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	107.37	21.52	5.85	4.18	1.04	0.00	0.84	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	93.27	18.98	7.81	3.63	1.48	0.54	0.67	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	114.61	29.46	8.34	6.13	0.34	0.17	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	109.70	28.92	5.78	4.63	2.31	0.39	0.96	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	100.58	20.29	5.33	3.61	1.38	0.34	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	102.33	24.14	6.45	3.57	0.55	0.27	0.55	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	113.77	25.45	6.40	2.46	1.31	0.33	0.16	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	119.13	16.19	3.75	3.24	0.68	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	83.45	19.38	3.55	2.81	1.63	0.30	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	132.48	21.59	4.00	3.73	0.27	0.53	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	132.87	17.15	3.32	1.94	0.41	0.00	0.41	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.86	16.67	2.86	0.95	0.71	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	186.83	23.78	5.24	2.22	0.20	0.60	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	87.68	12.90	2.54	2.54	0.75	0.09	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	102.71	16.42	2.45	1.75	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	118.17	25.08	2.72	2.72	0.00	0.00	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	96.93	13.10	3.06	2.08	2.08	0.37	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	264.18	34.35	4.80	5.09	1.75	0.29	0.73	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	96.13	15.82	1.22	1.83	1.83	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	86.50	13.56	1.51	1.81	0.90	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	112.42	19.23	2.26	2.04	0.68	0.45	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	146.48	22.17	2.10	2.70	1.20	0.90	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	116.19	11.81	2.24	2.24	0.59	0.00	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	109.71	18.14	4.06	2.77	0.64	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	132.22	31.85	4.21	2.40	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	34.23	12.79	3.20	3.01	0.19	0.56	0.00	0.56
Schwann Cells, donor2	11578-120F3	30.62	6.80	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.19	4.60	1.75	2.85	0.44	1.10	0.00	0.00
Sebocyte, donor1	11220-116B5	26.84	9.86	4.38	2.19	0.00	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	16.54	10.57	3.22	2.30	0.92	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	24.73	10.10	1.86	0.41	0.21	0.00	0.00	0.21
Sertoli Cells, donor1	11255-116F4	24.85	3.31	1.66	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	90.38	0.00	0.00	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.22	5.54	1.14	1.06	0.18	0.00	0.00	0.00
Skeletal Muscle Cells, donor2	11358-117H8	13.73	3.61	1.45	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	34.28	12.54	8.36	2.51	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.84	9.58	2.36	2.20	0.31	0.63	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	23.93	12.04	3.12	1.49	0.59	0.15	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	22.47	11.54	5.85	5.54	0.77	0.46	0.46	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	40.20	10.46	0.76	1.89	0.50	0.25	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	40.81	12.27	2.28	1.71	1.14	0.14	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.16	11.41	5.26	2.88	0.50	0.30	0.10	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.86	4.63	1.18	1.10	0.25	0.34	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	24.61	13.03	5.07	2.17	0.00	0.00	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	21.60	4.27	2.20	3.03	0.69	0.41	0.00	0.00
Skin - palm, donor1	10286-104F7	37.61	18.80	0.00	8.06	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.08	3.32	1.15	0.58	0.14	0.29	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	103.05	27.81	7.36	4.09	0.82	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.29	3.76	1.04	0.91	0.26	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	5.84	4.87	1.11	0.70	0.28	0.00	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	13.36	10.41	3.09	1.83	0.00	0.00	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	52.86	29.39	9.09	4.23	2.75	0.21	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	7.79	11.47	1.80	1.12	0.07	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.71	3.70	2.16	2.78	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	38.02	4.89	2.89	4.22	0.89	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	2.94	1.76	5.29	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	27.62	3.31	0.66	1.55	0.22	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	4.73	3.15	2.36	0.39	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	14.68	6.18	3.86	6.18	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	40.03	1.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.83	3.59	1.46	1.73	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.30	5.76	1.77	1.99	0.22	0.22	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.16	3.71	1.41	2.43	0.64	0.00	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	20.84	1.95	1.30	1.30	0.00	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	25.69	2.66	1.77	2.07	0.89	0.59	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	20.36	3.84	1.42	1.42	0.43	0.14	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.22	3.90	1.95	1.63	0.16	0.16	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.01	5.18	1.83	1.22	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.29	3.54	2.78	2.53	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	12.24	0.00	12.24	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	18.60	7.63	3.34	5.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.86	5.01	0.88	1.62	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.21	6.46	1.51	1.51	1.08	0.00	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.55	5.46	1.47	1.05	1.26	0.31	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	20.42	3.71	2.32	3.09	0.31	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	10.78	3.23	2.16	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.25	6.57	2.39	2.09	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	41.99	10.92	2.05	2.73	1.71	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	42.64	6.44	0.94	0.63	0.47	0.00	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.44	2.01	2.42	2.52	0.50	0.30	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.43	8.19	3.41	4.10	0.46	0.23	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	4.83	3.02	7.25	0.00	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.44	8.74	2.91	3.18	1.32	0.79	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	22.77	4.53	1.46	3.86	1.33	0.53	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	28.42	5.26	1.00	2.75	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	15.47	2.03	0.51	1.78	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	19.75	3.47	1.81	1.51	0.45	0.45	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	7.50	6.75	3.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	180.91	9.05	6.46	5.17	0.00	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.55	6.51	1.86	1.40	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	4.04	1.01	2.52	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.04	5.95	2.51	3.76	0.63	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.27	2.95	0.88	1.47	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	21.24	7.25	2.83	3.00	0.83	0.08	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	32.23	4.20	0.93	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.85	4.89	1.87	1.87	0.00	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	17.59	8.67	3.82	1.78	0.51	0.25	0.00	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.75	7.71	3.95	2.44	0.00	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	23.34	7.55	2.66	1.82	0.56	0.42	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	13.57	4.02	0.67	1.01	0.34	0.00	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.48	7.62	0.95	0.95	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	14.68	4.40	1.71	1.71	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.36	3.31	1.99	1.10	0.66	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.48	1.46	3.22	2.93	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.98	3.50	0.78	0.97	0.39	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	19.31	1.59	1.85	1.59	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	16.37	1.86	0.00	1.86	0.00	1.12	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.08	2.52	2.16	2.16	0.36	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	12.49	2.27	0.57	2.84	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	23.63	3.94	1.58	3.15	0.00	0.00	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	30.22	1.52	1.02	0.76	0.25	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	55.51	6.39	2.80	2.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	29.68	2.09	1.25	1.25	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	32.54	2.75	0.92	1.38	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	13.97	2.52	1.68	2.36	0.67	0.34	0.00	0.17
Synoviocyte, donor2	11368-117I9	15.92	7.21	1.17	0.84	1.34	0.17	0.00	0.00
Synoviocyte, donor3	11440-118H9	14.75	6.26	1.34	1.12	0.89	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	36.81	16.08	4.29	3.57	0.36	0.00	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	23.78	11.89	1.98	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	33.34	12.04	2.32	2.78	0.00	0.00	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	9.89	6.88	3.30	1.00	0.14	0.00	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	7.73	4.64	1.93	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	8.59	9.16	2.29	1.72	0.00	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	47.98	10.33	1.48	1.23	1.48	0.12	0.00	0.00
Urethra, donor2	10319-105A4	73.74	14.39	1.80	3.60	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	12.22	5.84	2.66	1.33	0.27	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	11.22	8.41	2.80	0.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	13.06	7.79	3.21	0.23	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	12.48	7.80	4.24	0.67	0.22	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	54.28	30.25	0.00	1.78	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	25.73	4.29	2.86	0.00	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	47.92	23.96	0.68	3.42	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	51.65	15.50	2.75	2.41	1.03	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	66.82	15.69	1.74	2.91	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	47.90	21.87	1.04	2.08	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	43.14	29.37	0.92	2.75	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	38.34	13.69	0.91	4.56	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	44.29	11.10	1.36	0.99	0.49	0.12	0.37	0.25
Wilms' tumor cell line:HFWT	10597-108E3	40.48	22.00	0.00	0.00	0.00	0.88	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	108.93	24.58	6.98	3.91	0.00	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	20.67	12.40	12.40	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	46.15	17.85	3.31	1.53	0.00	0.00	1.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	74.06	31.58	0.93	2.09	0.23	0.23	1.16	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	128.09	40.12	2.02	1.19	0.83	0.24	0.83	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	34.29	18.50	2.45	1.36	0.82	0.54	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	81.23	22.49	4.50	2.25	0.56	0.56	2.25	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	36.37	11.21	2.75	1.90	0.00	0.21	1.48	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	57.44	14.16	2.18	2.18	0.54	1.36	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	33.49	29.52	2.20	0.44	0.44	0.44	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.84	15.93	0.82	2.04	0.00	0.00	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	76.49	34.17	3.49	2.33	3.11	2.33	3.11	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	33.12	17.48	4.23	2.58	0.37	0.18	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	70.21	46.81	15.60	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.52	9.30	3.49	1.86	0.00	0.23	0.46	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	81.81	26.15	2.07	3.11	3.37	1.29	1.04	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	66.34	26.59	3.51	3.21	2.92	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.42	15.34	1.86	2.32	0.00	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	43.59	21.39	2.06	0.82	0.00	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.95	12.89	3.68	2.15	0.00	0.00	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	15.79	19.20	3.41	1.28	0.00	0.43	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	26.99	13.04	2.43	1.52	0.00	0.00	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	24.79	14.68	1.93	3.61	0.24	0.00	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	32.30	28.96	4.90	2.67	0.45	0.22	2.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	44.03	20.01	7.67	3.34	0.00	0.33	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	141.22	31.59	11.15	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	56.50	14.69	1.88	1.51	0.00	1.13	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	103.80	32.71	6.11	3.05	0.44	0.87	4.36	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	41.24	7.50	0.00	3.75	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	14.37	14.37	1.41	0.47	0.24	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	57.24	10.70	1.24	2.02	0.16	0.47	0.00	0.00
adipose, donor1	10184-103D4	163.61	35.77	2.35	4.69	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	165.05	22.71	0.81	0.81	0.41	0.41	0.41	0.41
adipose, donor3	10186-103D6	98.02	14.98	2.18	3.27	0.54	0.00	0.82	0.82
adipose, donor4	10187-103D7	53.74	16.47	0.00	0.87	0.00	0.00	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	59.81	14.68	3.79	0.63	0.95	1.26	0.79	0.16
adrenal gland, adult, pool1	10081-102A9	29.10	25.46	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	44.16	48.43	6.00	2.67	4.40	4.40	0.67	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	68.96	18.58	3.93	2.86	1.07	1.07	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	12.29	3.94	0.46	0.93	0.93	0.23	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	30.09	4.73	2.03	1.01	0.68	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	12.08	5.60	0.59	1.18	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	24.90	7.11	2.37	2.37	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	57.38	12.77	8.11	4.46	0.61	0.20	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	51.00	2.90	3.23	1.29	0.00	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	74.62	17.44	2.80	2.16	0.51	0.13	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	23.39	23.61	3.75	4.85	7.50	0.22	0.88	8.38
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.51	25.39	9.02	2.67	0.00	0.33	0.00	0.67
aorta, adult, pool1	10052-101G7	39.42	11.18	1.37	1.18	0.20	0.59	0.20	0.00
appendix, adult	10189-103D9	91.98	39.98	8.93	5.05	1.16	0.78	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	58.13	17.20	2.41	1.38	0.00	0.34	0.00	0.69
artery, adult	10190-103E1	38.04	17.66	1.36	4.08	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	50.85	4.49	1.30	0.58	0.14	0.29	0.14	0.00
b cell line:RPMI1788	10427-106D4	53.53	22.75	1.49	0.89	1.78	1.93	1.04	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.10	3.61	1.39	3.88	0.28	0.28	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	32.15	16.37	5.95	3.97	0.89	0.00	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	17.41	10.54	1.34	0.67	0.00	0.17	0.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	17.34	10.63	3.36	2.24	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	57.91	11.62	0.65	1.30	0.00	0.33	0.00	0.11
blood, adult, pool1	10053-101G8	17.72	31.00	2.21	6.64	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	24.83	11.13	3.43	5.99	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	45.21	6.07	3.37	2.02	0.00	2.70	0.00	0.00
brain, adult, donor1	10084-102B3	34.85	5.13	3.08	1.03	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	25.84	6.01	3.56	2.23	0.67	0.22	0.33	0.00
brain, fetal, pool1	10085-102B4	64.11	18.70	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	24.12	10.90	2.64	0.99	0.00	0.00	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.82	13.98	3.74	2.25	0.25	0.37	0.50	0.00
breast, adult, donor1	10080-102A8	35.36	18.31	1.89	1.89	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.96	18.55	4.45	1.65	0.38	0.00	0.64	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	50.71	15.15	0.93	1.24	0.00	0.00	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	50.88	20.26	2.76	0.23	2.07	0.00	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	43.09	7.75	2.18	1.21	0.24	0.00	0.00	0.73
carcinoid cell line:NCI-H1770	10703-109H1	63.00	26.80	2.82	1.41	0.00	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	101.18	25.38	3.50	2.08	1.64	0.00	0.66	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	50.39	22.50	2.85	0.63	0.32	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	101.15	18.37	1.06	1.33	0.27	0.27	0.53	0.53
caudate nucleus - adult, donor10196	10177-103C6	41.45	18.42	2.30	1.15	1.15	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	44.34	14.72	4.18	1.67	0.67	0.50	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	10.70	1.53	3.82	2.29	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	67.75	6.23	2.93	0.73	1.10	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	93.22	23.31	8.74	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	116.79	36.08	7.05	4.06	0.64	0.00	1.07	0.00
cerebellum, adult, pool1	10083-102B2	22.08	9.31	3.10	1.72	0.00	0.00	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	234.97	23.25	2.49	2.49	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	23.20	5.29	6.05	3.53	0.25	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	10.23	10.23	0.00	1.46	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	39.25	14.09	0.86	0.72	0.29	0.00	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	25.35	9.11	0.66	0.33	0.83	0.00	0.00	0.00
cervix, adult, pool1	10013-101C4	119.58	8.82	1.15	1.47	0.21	0.42	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.89	17.28	2.09	1.67	0.98	0.14	0.28	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	24.82	9.14	6.53	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	89.73	23.86	2.11	0.62	0.25	0.00	0.25	0.25
choriocarcinoma cell line:SCH	10785-110H2	94.75	27.11	4.44	1.36	0.00	0.00	0.37	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	36.76	35.10	3.79	0.00	0.24	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	25.36	5.13	1.14	0.28	1.14	0.00	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	47.93	5.27	1.79	2.29	0.99	0.10	0.10	0.10
chorionic membrane cells, donor3	12240-129G8	48.35	8.24	1.10	0.00	0.55	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	25.25	16.16	2.02	5.05	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.89	20.75	3.84	2.31	0.38	0.38	1.15	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	35.48	12.04	2.53	1.69	0.84	0.21	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	49.31	27.48	1.28	0.77	0.51	0.51	0.77	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.49	33.86	1.94	1.69	0.48	0.24	1.21	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	66.78	32.17	2.65	1.43	0.61	0.20	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	35.92	37.40	2.65	2.06	0.59	0.29	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	54.21	15.38	1.04	0.00	0.52	0.26	1.56	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.15	20.57	2.97	0.91	1.83	0.69	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	102.20	13.88	2.95	2.08	0.87	0.17	0.17	0.52
colon carcinoma cell line:CACO-2	10513-107D9	109.46	20.13	3.48	1.28	2.38	0.73	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	105.28	23.18	1.90	1.14	0.00	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	41.65	28.56	3.57	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	58.16	11.99	2.59	1.18	1.29	0.24	0.35	0.00
colon, fetal, donor1	10070-101I7	56.85	22.87	1.24	0.00	3.09	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	339.18	146.67	41.25	13.75	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	99.43	35.69	8.07	5.10	10.20	8.92	0.85	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	55.09	15.40	3.92	3.47	5.74	11.77	1.36	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	36.66	15.79	5.36	5.50	6.77	13.96	1.83	0.28
corpus callosum, adult, pool1	10042-101F6	59.92	16.03	2.32	1.66	2.10	0.55	0.77	0.00
cruciate ligament, donor2	10295-104G7	37.28	17.02	4.05	6.48	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	39.33	20.87	0.80	2.41	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	18.96	6.96	2.64	0.96	0.24	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	36.28	18.14	2.53	2.76	1.38	0.92	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	83.34	22.57	4.36	2.31	0.51	0.00	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.00	6.50	0.72	0.96	0.48	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	36.88	17.44	4.98	1.00	0.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	47.53	12.96	0.00	0.00	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	96.37	14.71	2.21	3.68	5.89	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	48.07	10.65	1.32	1.73	0.74	0.66	0.58	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	146.57	32.64	3.78	3.11	0.67	0.00	0.67	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	71.93	17.48	2.01	2.15	0.14	0.29	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	56.11	35.76	6.17	6.17	2.47	0.00	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	47.83	24.22	2.12	0.61	0.30	0.00	0.00	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.74	29.02	4.32	2.16	0.93	0.00	1.54	0.31
embryonic pancreas cell line:2C6	10603-108E9	52.54	27.58	6.57	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	73.74	17.43	1.34	1.68	1.01	0.00	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.24	7.79	0.91	0.36	1.27	0.36	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.87	4.18	1.13	0.16	0.48	0.00	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	58.69	16.90	6.56	2.67	0.67	0.22	0.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	46.96	34.76	8.58	5.50	2.20	0.11	0.44	0.44
epididymis, adult	10197-103E8	57.77	13.81	3.14	1.05	1.05	0.63	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.37	7.98	2.84	1.06	1.77	2.13	0.53	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	56.63	6.29	1.18	3.15	0.79	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	59.63	36.96	6.55	3.01	1.31	0.26	1.31	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	65.84	41.93	5.22	2.66	2.56	0.00	1.77	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	59.60	39.77	6.83	3.58	1.79	0.22	1.34	0.56
esophagus, adult, pool1	10015-101C6	29.62	7.86	0.85	1.38	0.64	0.11	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	109.58	2.38	1.00	0.50	0.13	0.50	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	72.44	14.49	7.24	0.00	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	14.73	2.10	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	22.32	10.42	4.46	0.00	0.00	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	29.81	14.90	1.15	1.15	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	24.78	17.49	4.37	10.20	1.46	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	40.17	5.85	0.51	0.76	0.00	0.00	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	29.88	10.90	1.54	0.90	0.26	0.00	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	101.62	23.27	7.36	3.56	0.00	0.24	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	27.02	6.66	3.19	1.60	0.66	0.19	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	70.56	15.61	2.70	0.90	1.80	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	52.30	13.62	2.83	1.10	0.18	0.18	0.18	0.09
gall bladder, adult	10198-103E9	53.84	12.07	2.17	1.45	0.72	0.24	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	60.66	14.50	2.68	1.07	0.00	0.54	1.61	0.00
gamma delta positive T cells, donor2	11938-126A3	41.83	5.98	1.12	2.24	0.00	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	60.83	9.29	3.38	1.06	0.63	0.21	0.00	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	42.16	17.41	0.97	0.97	1.35	0.00	0.19	0.77
gastric cancer cell line:AZ521	10549-107H9	61.32	10.49	1.15	0.33	0.82	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	79.62	50.34	6.41	3.66	0.92	0.92	0.92	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	113.54	14.39	2.74	2.06	0.69	0.23	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	3.90	9.29	1.26	0.46	0.11	0.00	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	95.45	8.96	3.64	2.38	1.54	0.56	0.00	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	22.70	16.71	5.99	2.24	0.00	0.00	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	40.95	11.19	2.74	3.27	1.06	0.84	0.42	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.08	9.97	3.23	1.83	0.56	0.42	0.28	0.98
glioblastoma cell line:T98G	10485-107A8	58.94	13.13	2.21	2.21	1.77	0.99	0.11	0.55
glioma cell line:GI-1	10413-106B8	56.23	8.79	1.76	1.46	0.29	0.29	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	18.22	15.31	4.37	1.46	0.00	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	65.91	25.63	5.13	2.69	1.95	0.24	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	42.45	9.58	1.37	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	51.16	8.53	1.60	2.66	0.53	0.53	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	301.00	144.38	26.92	22.02	0.00	0.00	7.34	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	15.68	0.00	0.00	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	43.84	8.32	2.56	2.24	0.32	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	29.84	10.10	0.00	0.92	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	25.61	7.77	1.37	0.00	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	31.56	12.88	0.64	0.64	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	14.37	5.75	0.00	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	20.58	10.29	0.00	0.00	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	22.07	8.83	2.21	0.00	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	49.14	16.38	3.16	3.16	2.87	4.60	0.57	0.57
heart - mitral valve, adult	10205-103F7	44.25	14.35	2.39	2.69	0.30	0.30	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	54.39	14.90	1.31	2.88	0.00	1.05	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	65.78	43.30	4.16	9.16	2.50	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	41.22	14.49	2.45	1.02	0.61	0.20	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	24.70	12.35	1.28	1.28	0.43	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	31.51	13.57	1.61	1.38	0.23	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	97.96	16.43	0.82	0.62	0.51	0.21	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.13	5.55	3.09	1.85	0.00	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	102.27	88.00	7.14	3.57	0.00	0.00	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	131.93	34.25	4.20	3.09	1.33	1.10	0.44	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	120.16	35.20	5.46	2.06	1.70	0.97	0.36	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	148.35	38.91	5.66	2.93	1.21	1.72	0.61	0.40
hepatoma cell line:Li-7	10484-107A7	50.83	11.79	1.00	1.00	0.33	0.00	0.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	22.91	14.97	2.41	0.80	0.20	0.20	0.60	0.20
hippocampus - adult, donor10196	10169-103B7	30.28	17.03	4.73	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	66.74	18.37	7.35	4.29	0.61	0.41	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	27.39	2.49	5.48	1.99	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	47.23	5.29	1.76	1.41	0.00	0.00	0.00	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.70	9.16	0.00	0.00	0.00	0.00	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.30	9.82	0.20	0.20	0.39	0.00	0.00	1.96
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	23.36	6.09	0.25	0.25	0.00	0.00	0.25	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	119.54	23.12	1.13	0.56	0.00	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	100.19	26.85	1.03	2.84	0.26	0.00	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	109.33	17.84	0.76	0.76	0.00	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	149.77	14.89	1.46	3.80	0.00	0.00	0.00	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	104.05	20.47	0.65	2.15	0.00	0.22	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	117.61	14.18	2.92	2.92	0.00	0.00	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	59.67	7.58	2.60	1.18	1.18	0.24	0.47	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	73.45	16.07	2.09	2.25	0.16	0.32	0.00	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	59.92	8.08	0.67	0.00	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.69	13.14	0.47	0.16	0.16	0.00	0.16	1.56
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.14	12.77	0.49	0.00	0.00	0.00	0.00	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	29.67	6.98	0.00	0.00	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	202.94	58.99	3.63	5.73	0.57	0.00	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	191.87	57.13	2.62	6.11	0.00	0.00	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	284.36	33.98	2.50	2.50	0.50	1.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	133.76	15.82	1.70	2.07	0.57	0.00	0.75	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	123.68	12.73	0.45	2.73	0.45	0.91	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	178.86	13.16	0.63	2.82	0.00	0.94	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	81.98	14.70	1.31	1.47	0.00	0.49	0.16	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	74.32	15.68	1.45	1.45	0.58	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	131.83	20.63	0.60	2.99	0.30	1.20	0.30	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.20	8.13	0.55	0.18	0.00	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	19.40	11.98	0.00	0.29	0.00	0.00	0.00	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.32	8.57	0.00	0.41	0.82	0.00	0.00	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	101.75	15.49	1.76	2.11	0.00	0.00	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	91.22	21.54	1.90	0.63	0.00	0.00	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	118.02	19.37	1.21	2.12	0.00	0.30	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	63.61	12.93	0.52	0.00	1.55	0.00	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	58.45	15.28	1.33	1.33	0.00	1.33	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	77.22	6.41	1.54	0.77	0.00	0.51	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	52.15	6.65	0.51	1.28	0.00	0.00	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	53.01	12.12	2.27	1.51	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	81.33	6.39	0.67	1.34	0.00	0.67	0.00	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	24.15	10.38	0.00	0.48	0.00	0.24	0.24	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	28.97	9.36	0.45	0.45	0.45	0.00	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	25.85	8.78	0.49	0.00	0.00	0.00	0.00	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	116.13	24.76	1.53	4.89	0.31	0.31	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	117.12	26.03	3.25	0.00	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	112.85	13.57	2.32	2.98	0.66	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	88.66	13.14	1.09	0.00	0.00	0.55	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	99.16	6.88	0.72	0.72	0.72	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	99.29	8.19	1.78	1.42	0.00	0.36	1.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	88.31	9.55	1.19	2.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	88.30	9.89	1.63	1.22	0.81	0.27	0.00	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	87.01	9.70	2.69	1.08	0.54	0.00	0.00	0.54
immature langerhans cells, donor1	11904-125F5	51.58	7.02	2.91	3.63	0.48	0.48	0.00	0.73
immature langerhans cells, donor2	11905-125F6	52.28	7.92	5.54	4.75	1.58	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	36.53	7.38	6.06	1.89	0.09	0.19	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	27.31	6.50	3.25	0.65	0.00	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	37.15	10.91	1.80	1.90	1.90	0.40	0.00	0.00
kidney, fetal, pool1	10045-101F9	121.03	9.27	1.70	0.35	0.78	0.57	0.28	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	120.43	10.37	1.28	0.99	0.28	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	16.31	7.05	0.69	0.28	0.55	0.00	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	35.23	21.47	4.04	2.20	0.55	0.00	0.55	0.18
left atrium, adult, donor1	10079-102A7	23.97	6.54	0.54	1.63	0.54	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	17.19	9.61	0.51	1.01	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	44.05	9.03	0.27	3.01	0.27	0.82	0.00	1.09
leiomyoma cell line:10964C	10569-108B2	10.78	3.23	2.51	0.72	0.00	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	7.07	1.63	2.72	1.63	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	6.80	1.21	1.46	1.70	0.00	0.00	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	74.23	33.46	4.18	4.18	0.00	1.05	0.00	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	67.18	19.72	2.48	1.30	0.83	0.12	0.59	0.47
liposarcoma cell line:KMLS-1	10782-110G8	18.59	7.81	3.28	3.91	0.47	0.31	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	80.41	15.11	3.29	3.78	0.85	0.37	0.61	0.00
liver, adult, pool1	10018-101C9	32.74	8.10	1.62	2.43	0.16	0.00	0.16	0.00
liver, fetal, pool1	10086-102B5	26.34	25.40	2.82	0.94	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	38.21	14.00	3.21	2.92	0.29	0.15	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	49.83	19.56	4.98	2.58	1.29	0.18	0.74	0.18
locus coeruleus, adult, donor10258	10375-105G6	21.72	5.64	0.85	0.28	0.00	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	71.08	6.31	1.26	1.26	0.00	0.42	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	19.79	9.13	0.83	0.28	0.42	0.00	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	71.70	11.03	0.00	1.38	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	87.79	17.80	2.50	1.45	0.13	0.26	0.66	0.13
lung, adult, pool1	10019-101D1	59.89	14.77	2.01	1.54	0.59	0.59	0.24	0.12
lung, fetal, donor1	10068-101I5	220.05	24.55	1.71	0.86	0.00	0.57	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	52.69	21.54	2.29	2.29	0.46	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	35.98	17.04	2.37	3.79	0.00	0.95	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	35.73	30.47	3.29	1.53	0.44	0.00	0.66	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	42.41	19.92	3.02	1.96	3.17	2.72	0.45	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	17.84	5.95	3.40	1.70	0.00	1.70	0.00
mature adipocyte, donor1	12231-129F8	100.34	18.20	0.89	4.88	5.33	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	87.16	14.11	2.70	1.87	2.49	0.42	0.42	1.25
mature adipocyte, donor3	12233-129G1	77.99	10.19	2.13	2.37	3.56	0.71	0.24	0.24
mature adipocyte, donor4	12234-129G2	80.28	10.53	1.84	2.63	1.84	0.53	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	91.49	30.26	2.38	1.67	0.71	0.00	1.67	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	21.43	6.77	3.38	3.38	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	54.07	18.21	5.70	4.41	0.37	0.00	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	20.97	5.08	3.18	0.95	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	51.18	5.12	3.41	1.71	0.00	2.56	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	30.88	9.45	6.58	2.70	0.17	0.34	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	62.61	18.68	9.55	4.88	0.85	1.06	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	7.71	1.93	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	43.06	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	48.46	5.03	3.95	1.44	0.00	0.00	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	36.99	8.44	2.60	2.60	1.30	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	56.04	19.97	3.25	1.55	0.93	0.00	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	37.71	10.04	3.59	1.96	0.49	0.24	0.24	0.08
medulla oblongata, newborn, donor10223	10361-105F1	78.46	7.64	0.69	0.69	0.69	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	164.07	17.71	1.77	2.21	0.00	0.22	0.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	47.20	21.64	5.62	3.18	0.37	0.24	0.73	0.12
melanoma cell line:COLO 679	10514-107E1	49.88	5.32	1.72	1.58	0.57	0.00	0.00	0.29
melanoma cell line:G-361	10465-106H6	40.99	9.23	2.71	1.90	0.81	0.27	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	13.93	9.41	1.63	1.09	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	85.47	27.32	3.52	2.64	0.00	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	74.92	19.18	3.37	1.04	0.52	0.26	0.52	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.04	5.98	3.07	3.68	0.46	0.77	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	13.63	4.00	2.36	2.00	0.73	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	2.48	7.45	3.31	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.32	2.67	1.83	3.37	0.56	0.14	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.18	3.66	2.12	1.73	0.00	0.00	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.88	0.69	0.69	0.69	0.00	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	11.84	3.95	1.89	2.06	0.00	0.17	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.03	2.65	2.42	1.96	0.92	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.46	4.24	1.33	2.39	0.40	0.27	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.34	3.38	3.38	3.11	0.27	0.14	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.50	5.26	2.28	3.27	0.28	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	17.46	7.25	1.65	2.31	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.60	4.15	2.77	2.08	0.55	0.55	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	19.55	3.49	1.40	4.89	0.70	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.76	3.67	3.27	2.04	0.20	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.93	2.16	2.52	0.00	0.72	0.00	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	16.14	3.93	1.86	1.14	0.41	0.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	13.00	2.51	1.60	0.91	0.46	0.23	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	13.43	5.03	2.52	3.78	0.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.90	3.29	1.64	2.84	1.05	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	18.38	3.59	1.23	1.84	0.26	0.18	0.09	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.87	5.52	4.05	2.21	0.37	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	26.04	3.43	0.86	2.58	0.00	0.29	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	31.16	7.16	2.53	3.37	0.42	0.42	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	19.18	3.20	0.91	0.91	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	22.25	3.07	1.28	2.05	0.77	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.20	4.97	1.31	2.09	0.26	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.41	3.70	0.92	0.62	0.00	0.31	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.06	3.53	1.18	1.65	0.47	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	3.72	1.02	1.35	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.61	7.47	2.36	1.57	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	25.02	1.85	1.39	0.46	0.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	21.63	2.88	2.31	1.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	19.41	3.79	0.45	1.78	0.22	0.00	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.15	2.40	0.48	1.92	0.00	0.48	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	1.47	2.20	1.47	0.73	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	20.81	2.35	3.02	0.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	17.60	3.68	0.82	1.23	0.00	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.33	6.01	1.29	0.43	0.00	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	8.20	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.99	3.25	1.30	0.97	0.32	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	2.91	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	2.67	0.53	2.67	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	2.45	2.45	0.82	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.50	3.50	1.17	1.17	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	2.10	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	2.98	0.99	2.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	12.45	1.78	1.78	1.78	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	3.66	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	3.17	1.90	0.63	1.27	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.52	4.48	0.00	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	6.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	6.89	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	14.67	2.04	0.00	0.81	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	3.97	0.00	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	2.95	1.18	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.27	1.87	1.87	1.25	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	17.38	8.02	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	4.73	1.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	5.14	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.90	2.07	1.38	0.69	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.81	2.97	0.49	0.49	0.49	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	7.85	3.36	1.12	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.08	2.54	1.27	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.16	2.42	0.40	0.81	0.00	0.00	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	6.54	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	3.80	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.81	8.50	0.61	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	5.77	0.00	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.91	2.58	0.60	0.00	0.00	0.00	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.68	4.54	0.65	0.00	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	2.04	1.02	2.04	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.20	13.93	3.09	0.77	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	82.68	25.04	1.89	1.65	4.02	0.71	0.47	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	55.14	8.34	1.85	0.00	0.70	0.23	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	94.02	8.55	0.00	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	76.75	3.08	0.92	1.23	0.92	1.64	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	66.04	16.79	1.13	0.68	0.68	0.00	0.23	0.91
mesothelioma cell line:Mero-41	10851-111F5	39.60	14.42	2.20	5.87	0.98	0.49	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	41.85	10.85	4.87	3.99	1.77	1.11	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	59.92	10.25	0.79	2.10	1.84	1.05	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	48.68	6.13	1.53	2.55	7.83	4.77	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	42.72	9.10	2.78	1.01	0.76	1.01	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	64.18	9.73	2.48	2.69	0.62	0.21	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	56.82	14.25	7.79	5.30	1.16	0.33	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	35.84	7.96	2.35	2.53	2.17	0.90	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	49.88	8.03	1.71	1.54	1.71	0.34	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	27.23	15.27	0.76	0.25	0.00	0.25	0.25	1.53
mesothelioma cell line:No36	10857-111G2	70.46	17.29	1.63	3.59	1.30	0.65	0.98	0.98
mesothelioma cell line:ONE58	10858-111G3	37.12	9.75	4.34	4.06	1.63	0.54	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	38.96	12.28	1.73	2.69	0.19	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	27.11	10.99	1.59	3.18	0.12	0.24	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	44.87	11.85	4.49	2.15	0.18	0.00	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	72.15	23.83	1.63	0.65	0.65	0.33	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.51	6.78	1.91	1.06	0.42	0.00	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.97	17.28	3.46	1.38	0.23	0.00	0.69	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.16	11.99	2.47	2.47	8.37	5.71	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	46.01	28.46	4.80	2.77	0.37	0.18	1.85	0.18
myeloma cell line:PCM6	10474-106I6	25.10	16.01	2.37	0.59	0.20	0.00	0.59	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.60	16.74	6.59	4.57	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	45.70	18.04	11.57	13.53	2.94	0.98	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.68	4.35	1.00	0.67	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.82	5.00	1.25	1.10	0.00	0.00	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	9.94	4.97	0.55	1.66	0.00	0.00	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	165.87	51.99	5.06	3.22	0.92	0.00	1.38	0.46
neuroblastoma cell line:NB-1	10539-107G8	49.76	18.33	1.87	2.81	0.37	0.00	1.12	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	67.06	16.87	0.42	0.21	0.63	0.21	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	150.76	23.48	1.49	1.12	0.56	0.19	0.37	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	111.73	14.71	0.71	0.95	0.00	0.00	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	159.65	14.57	3.17	2.22	1.27	0.63	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	64.81	11.67	1.81	1.01	0.00	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	105.54	18.44	3.81	1.91	1.27	0.00	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	33.27	6.65	1.86	1.60	0.53	0.27	0.27	0.00
neutrophil PMN, donor1	12133-128D9	44.62	74.37	0.00	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	9.47	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	186.03	28.41	0.51	0.51	0.00	2.20	0.68	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	22.41	11.21	0.80	0.00	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.55	3.53	0.64	0.64	0.64	0.64	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.18	4.73	2.10	2.63	0.26	0.00	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	33.00	7.03	3.66	1.97	1.03	0.19	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	47.39	18.54	2.06	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	68.70	30.59	15.30	6.17	0.54	0.54	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	47.31	3.64	2.55	2.55	0.36	0.00	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	19.16	7.35	4.20	2.62	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	128.30	26.60	6.87	2.57	0.00	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	21.92	6.70	2.21	2.37	0.63	0.24	0.16	0.00
olfactory region, adult	10195-103E6	32.67	7.26	7.26	3.06	0.38	0.19	0.00	0.19
optic nerve, donor1	10277-104E7	72.04	34.02	4.00	12.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.64	19.82	3.19	1.82	0.80	0.00	0.57	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	81.33	17.17	3.16	1.24	1.51	0.14	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	42.33	6.60	2.37	2.37	0.00	0.00	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.92	17.44	5.54	2.77	0.35	0.00	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	27.93	7.64	1.18	2.65	0.29	0.00	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	69.14	42.05	4.67	3.74	0.00	0.00	1.87	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	53.65	6.57	0.64	1.91	0.42	0.21	0.21	0.21
ovary, adult, pool1	10020-101D2	75.91	7.34	0.61	1.14	0.52	0.26	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.68	11.00	5.87	4.58	1.47	0.00	0.00	0.73
pancreas, adult, donor1	10049-101G4	35.74	16.93	2.82	1.88	0.94	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.09	42.49	6.15	1.68	0.28	0.00	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	73.42	19.08	3.75	2.56	1.36	0.17	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	50.01	10.93	2.48	3.64	0.33	0.33	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	21.87	6.13	2.56	2.01	0.55	0.18	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	19.08	2.94	1.47	2.20	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	18.81	14.11	2.82	0.94	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	50.17	16.25	9.98	4.56	0.29	0.29	1.14	0.00
parietal lobe, adult, pool1	10034-101E7	28.73	7.49	3.70	1.76	1.15	0.18	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	206.57	45.58	5.82	4.85	0.00	0.00	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	50.10	6.73	4.49	1.50	0.00	0.00	0.37	1.12
parotid gland, adult	10199-103F1	30.22	8.02	2.47	2.47	0.62	0.00	0.00	0.00
penis, adult	10200-103F2	47.27	15.04	1.07	2.15	0.00	0.54	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	41.28	15.25	1.30	2.23	0.37	0.00	0.37	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	46.91	11.51	0.73	1.31	0.29	0.15	0.58	0.44
pineal gland - adult, donor10196	10179-103C8	29.03	12.26	4.52	5.16	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	30.20	15.40	4.15	1.78	0.59	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	32.61	10.66	4.39	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	74.87	14.17	2.02	1.01	1.01	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	82.35	14.59	1.56	0.52	1.56	0.52	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	35.75	6.81	0.85	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	30.85	6.77	1.72	0.97	0.11	0.00	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	56.15	26.35	1.59	1.59	2.78	1.59	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.05	16.34	1.71	1.09	0.31	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	25.65	6.02	1.89	2.07	0.60	0.26	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	22.06	6.54	4.10	2.27	0.35	0.26	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	85.75	123.39	18.82	23.01	0.00	0.00	10.46	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	39.18	15.00	2.91	0.87	2.91	0.73	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	91.84	13.79	3.63	4.17	0.91	1.09	1.09	0.36
prostate, adult, pool1	10022-101D4	60.22	7.98	1.09	0.82	0.45	0.18	0.09	0.00
putamen, adult, donor10196	10176-103C5	40.13	11.09	4.72	1.65	0.94	0.24	0.24	0.00
putamen, adult, donor10252	10152-102I8	23.53	5.88	5.88	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	15.30	5.46	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	16.67	4.83	2.66	1.21	0.24	0.00	0.24	0.24
putamen, newborn, donor10223	10365-105F5	50.23	2.25	2.25	0.00	0.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	57.90	23.86	4.65	1.45	1.16	0.00	0.29	0.29
rectum, fetal, donor1	10067-101I4	72.33	23.65	2.78	1.39	0.00	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.52	12.51	1.06	2.97	0.21	1.06	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	53.02	8.28	0.41	0.00	1.24	0.41	0.00	0.41
retina, adult, pool1	10030-101E3	55.37	11.23	1.39	1.79	1.09	0.30	0.10	0.00
retinoblastoma cell line:Y79	10475-106I7	68.85	33.51	1.82	0.78	0.26	0.26	1.30	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	46.84	8.98	1.23	0.61	0.49	0.12	0.25	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	106.86	11.81	0.28	0.56	0.28	0.00	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	64.42	16.67	5.30	2.27	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	19.26	7.12	3.40	0.97	0.16	0.16	0.49	0.00
salivary acinar cells, donor2	11772-123I8	37.86	4.41	1.10	1.93	0.14	0.14	0.00	0.14
salivary acinar cells, donor3	11773-123I9	81.43	9.93	3.31	3.97	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	44.61	14.30	0.00	0.57	1.14	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	16.19	5.82	1.85	1.60	0.17	0.00	0.00	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.11	8.93	2.35	1.88	0.24	0.00	0.12	0.00
seminal vesicle, adult	10201-103F3	51.32	23.81	4.76	2.12	0.00	0.00	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.31	12.88	4.37	1.46	0.24	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	30.45	9.31	0.75	1.76	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	27.10	10.04	4.01	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	89.99	15.31	4.03	4.43	2.15	0.00	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	21.88	22.55	3.54	2.21	0.22	0.00	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.35	9.29	1.42	1.03	0.39	0.13	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	9.93	2.84	2.13	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	61.05	17.87	1.80	1.68	0.24	0.00	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	44.22	9.05	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	42.29	5.68	0.63	1.89	0.00	0.63	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	55.70	15.68	1.00	0.67	0.67	0.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	215.29	24.90	1.89	3.47	1.26	0.95	0.00	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	67.08	2.89	1.16	0.19	0.58	0.39	0.39	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	48.95	17.97	1.15	0.82	0.33	0.16	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	127.23	23.97	0.97	0.97	0.48	0.00	0.16	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.83	20.48	2.62	0.44	1.74	0.00	0.22	0.22
small intestine, adult, pool1	10024-101D6	33.21	15.17	1.55	2.63	1.67	0.24	0.24	0.00
small intestine, fetal, donor1	10064-101I1	24.32	10.81	2.21	1.47	8.35	0.98	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	32.83	20.52	4.10	2.56	0.00	0.00	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	39.03	12.66	1.55	2.07	0.00	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	43.69	19.30	2.41	0.80	0.00	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	33.26	16.98	4.13	3.90	0.23	0.00	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	45.34	8.28	2.37	0.79	1.58	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	31.13	6.92	0.69	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	63.42	10.98	4.88	1.22	1.22	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	67.96	8.73	0.46	1.38	0.00	0.00	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	23.60	8.66	3.58	3.58	1.05	0.15	0.45	0.00
spleen, adult, pool1	10025-101D7	64.10	14.21	2.42	1.76	0.66	0.66	0.55	0.11
spleen, fetal, pool1	10044-101F8	106.71	17.00	1.75	2.15	0.72	0.72	0.32	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	43.27	18.22	2.90	2.07	0.41	0.41	1.24	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	36.65	14.24	2.47	1.90	0.38	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	70.24	15.73	4.19	1.75	1.40	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	35.57	35.97	6.25	3.13	0.39	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.98	13.62	3.15	2.14	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.86	17.79	1.27	5.08	0.00	0.00	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	24.12	15.65	2.12	1.27	0.85	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	63.01	28.84	2.14	4.27	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	40.45	9.68	0.57	2.85	0.57	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	55.46	20.98	3.32	2.91	2.28	0.00	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	27.93	4.14	0.52	0.52	1.03	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	87.62	7.77	7.07	0.00	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	80.01	14.90	3.44	1.38	0.69	0.46	0.46	0.46
temporal lobe, adult, pool1	10031-101E4	27.47	6.53	4.15	3.05	0.68	0.08	0.17	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	137.47	20.66	3.56	2.14	0.00	0.00	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	165.27	20.66	7.03	4.83	0.44	0.44	1.32	0.00
tenocyte, donor1	11763-123H8	25.14	3.14	2.09	1.40	0.70	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	21.36	6.10	1.53	0.76	0.76	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	14.09	5.56	1.11	1.11	0.74	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	24.81	23.28	1.36	0.17	0.17	0.00	0.34	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	125.63	25.28	4.47	2.62	0.62	0.15	0.15	1.23
teratocarcinoma cell line:PA-1	10807-111A6	13.02	17.36	0.77	0.00	0.15	0.00	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.04	7.87	0.51	0.13	0.00	0.00	0.63	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.21	10.97	0.76	0.00	0.00	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	8.29	11.12	0.33	0.44	0.00	0.00	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	20.19	14.33	0.33	0.00	0.00	0.00	0.33	0.33
testis, adult, pool1	10026-101D8	53.69	11.70	2.58	1.50	1.07	0.32	0.21	2.90
testis, adult, pool2	10096-102C6	52.78	27.52	6.77	2.71	1.80	0.90	0.90	13.98
thalamus - adult, donor10196	10168-103B6	38.64	13.25	2.21	2.21	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	74.86	20.16	3.44	2.03	1.56	0.31	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	26.17	3.08	3.08	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.47	4.61	1.15	0.49	0.33	0.00	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	27.04	3.45	4.60	1.73	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	35.20	11.73	1.25	3.50	1.00	0.50	0.00	0.00
throat, fetal, donor1	10061-101H7	60.33	13.71	1.22	1.22	0.00	0.00	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	95.79	7.15	1.59	2.38	0.40	0.20	0.20	0.00
thymus, adult, pool1	10027-101D9	142.06	17.10	2.39	2.39	0.60	1.59	1.09	0.20
thymus, fetal, pool1	10043-101F7	183.50	16.73	2.81	1.45	2.60	2.39	0.31	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	63.02	18.48	6.12	5.85	1.33	0.00	0.53	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	89.26	27.24	3.21	2.93	3.07	0.56	0.56	0.98
thyroid, adult, pool1	10028-101E1	74.28	10.92	1.49	0.84	0.56	0.00	0.09	0.09
thyroid, fetal, donor1	10060-101H6	50.89	19.51	1.58	0.53	0.79	0.26	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	21.56	3.08	6.16	0.00	0.00	0.00	3.08
tongue, adult	10203-103F5	30.70	11.63	2.09	1.40	0.47	0.23	0.23	0.00
tongue, fetal, donor1	10059-101H5	23.25	8.28	0.79	0.00	0.39	0.39	0.39	0.00
tonsil, adult, pool1	10047-101G2	52.29	15.73	2.10	3.41	1.30	2.10	0.50	0.20
trachea, adult, pool1	10029-101E2	37.30	11.70	1.88	1.64	0.41	0.41	0.33	0.00
trachea, fetal, donor1	10058-101H4	57.32	9.23	1.15	1.92	0.00	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	14.88	6.73	3.54	3.54	0.00	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	60.79	14.69	3.65	2.84	0.51	0.10	0.20	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	77.72	26.01	1.72	1.88	2.98	1.25	1.10	0.47
tridermal teratoma cell line:HGRT	10694-109G1	79.91	30.44	3.81	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	36.48	18.45	2.45	0.93	0.42	0.34	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	39.64	6.26	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	115.17	18.09	1.71	2.22	0.00	0.17	0.34	0.17
uterus, fetal, donor1	10055-101H1	61.94	7.68	0.51	2.05	0.00	0.00	0.00	1.02
vagina, adult	10204-103F6	76.25	23.26	0.65	2.58	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	71.68	15.34	3.29	2.85	0.22	1.75	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	21.10	6.41	2.40	1.60	1.07	0.27	0.27	0.27